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ABSTRACT 
Vascular access via the radial artery has recently been shown to reduce access site 
related vascular complications but is associated with a significant learning curve. 
Radial artery spasm, arterial puncture failure, vascular anomalies, failure to reach the 
ascending aorta and concern regarding higher radiation exposure with the transradial 
are some obstacles that impede widespread uptake of this technique.  
 
This study was performed to assess some of these learning curve issues and to explore 
the use of transradial access in high-risk patient subgroups. Six interlinked projects 
were setup for this study and a total of 3125 patients evaluated. 
 
Access site vascular complications remain unacceptably high in contemporary 
practice as discussed in Chapter 2. The transradial approach could minimise such 
complications. 
 
Radial artery anomalies are relatively common and are a common cause of transradial 
procedure failure as detailed in Chapter 3. Forearm arterial diameter variations and 
the effect of sublingual GTN were discussed in Chapter 4. The radial artery is bigger 
than the ulnar artery and GTN increases their diameters by an average of 15-22%. The 
issues with radiation exposure were studied as detailed in Chapter 5. With strict 
control of various variables and optimal radiation protection, we demonstrated that 
there is no difference in radiation exposure between transradial and transfemoral 
diagnostic angiography when performed by an experienced operator.  
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The application of transradial technique in 2 high-risk patient subgroups was analysed 
as detailed in Chapter 6. Transradial rescue angioplasty for failed reperfusion and 
percutaneous right and left heart catheterisation via the arm approach without 
interruption to Warfarin therapy are found to be safe and effective. 
 
These findings have important clinical implication and may help shorten the learning 
curve and optimise procedure technique including high-risk patient subgroups, 
thereby help to further drive the adoption of transradial approach. 
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1.1 HISTORICAL PERSPECTIVE OF INVASIVE CARDIAC PROCEDURES  
 
“There are three stages in the history of every medical discovery. 
When it is first announced, people say that it is not true. Then, a little 
later, when its truth has been borne in on them, so that it can no longer 
be denied, they say it is not important. After that, if its importance 
becomes sufficiently obvious, they say that anyhow it is not new.” (1) 
     -Sir James Mackenzie, 1853-1925    
 
Amongst the greatest achievements in cardiovascular medicine in the past century has 
been the introduction, development and refinement of the invasive diagnostic and 
therapeutic modalities of cardiac catheterisation and related catheter-based 
interventions. The development of coronary angiography and angioplasty have 
revolutionised the diagnosis and management of cardiovascular disease in almost 
every way. The history of these techniques that have evolved over the last century is 
an exciting, instructive testament to the scientific spirit and method. Cournand, 
Richards and Forssmann, the three pioneers in cardiac catheterisation were awarded 
the Nobel Prize for Medicine or Physiology in 1956 (2).  
 
Cardiac catheterisation 
The early years 
The history of diagnostic and therapeutic catheterisation of hollow organ systems is 
ancient. The Egyptians are known to have performed bladder catheterisation in 3000 
B.C. using bronze, silver and gold pipes (3). Around the time of Hippocrates (400 
B.C.), air and water were pushed through hollow reeds or brass pipes into cadaver 
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aortas in an attempt to understand the function of the cardiac valves (4). Harvey 
catheterised the inferior vena cava of a cadaver in 1651 and proved that venous blood 
flowed toward the lungs not toward the periphery, contrary to prevailing opinion (4). 
The first intravenous injection into a living subject was performed in 1665 by Wren 
when he injected into a dog. Major became the first to deliver an injection into a 
human in 1667 (5). Lower, later used the first vascular catheter (silver pipes 
connected by a quill) to transfuse blood from the carotid artery of a sheep to the 
jugular vein of a human in the same year (5). 
 
The earliest known case of cardiac catheterisations of a living animal was performed 
by Stephen Hales in 1711, by inserting brass pipes through the venous and arterial 
systems into the ventricles of a horse via the jugular vein and the carotid artery (6) 
[Figure 1]. Variations on the technique were performed over the subsequent century, 
with formal study of the cardiac physiology of a dog by Claude Bernard in 1847 (7). 
Fick published his formula for calculating cardiac output using oximetric 
measurements in 1870 (8), which was validated by Grehant and Quinquaud in 1886 
using experimental right-heart and arterial catheterisation (9). 
 
The discovery of x-rays by Roentgen on November 8, 1895 played a pivotal in the 
subsequent developments in invasive cardiology (10). This led to production of 
fluoroscopic images of a beating heart by Williams (10), and the first cadaver’s 
brachial arteriogram by Haschek and Lindenthal, both in 1896 (11). Baumgarten in 
1899 performed the first coronary arteriograms on animal cadaver hearts (12). 
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Figure 1. First documented cardiac catheterisation, right and left heart study 
performed by Hales (left) in 1711. (From the Bettmann Archieves.) 
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Cardiac catheterisation of humans 
“The cardiac catheter was the key in the lock” 
      -Andre Cournand, 1895-1988  
 
Right heart catheterisation 
The first human heart catheterization was performed in July 1929 when Werner 
Forssman inserted a ureteric catheter into his own right atrium via a cut down of his 
left ante-cubital vein (13). He documented the position of the catheter in his right 
atrium with a chest roentgenogram (Figure 2).  
 
Figure 2. First documented human catheterisation investigating central delivery of 
drugs for cardiac arrest as 25-year-old surgical resident, Forssmann passed urethral 
catheter via left basilica vein cutdown into right atrium and then took this 
roentgenogram. (From Forssmann W. Klin Wochenschr 1929;8:2085-7) 
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Although Forssmann’s pioneering work was recognised as important from the start, 
he was nonetheless ridiculed and vilified as a “dangerous quack” by the medical 
community. He had been told by his superiors that “such methods are good for a 
circus, but not for a respected hospital” and that his “ideas were too crazy to give him 
a clinical position” (14). Finally discouraged by cardiac work, Forssmann turned to 
urology in 1931, served as a German army surgeon during World War II, and then as 
a country doctor after the war in a small town. Although he never engaged in cardiac 
research after 1931 or even held any cardiology faculty appointments, he was 
awarded a Nobel Prize in 1956, along with fellow catheterisation pioneers Cournand 
and Richards. Resisting the expectation of him to return to cardiology research, 
Forssmann concluded, “The subject has progressed too far in the interim, and when I 
considered it objectively I was certain I’d never catch up….. I decided it was more 
honest to content myself with the role of ‘leading fossil’” (15). Forssmann died of a 
myocardial infarction in 1979 without ever having returned to work in cardiology 
(16). 
 
Following Forssmann’s daring self-catheterisation, catheters were placed in a similar 
manner into the right ventricle by other pioneers over the next few years, and 
measurements of pressure and cardiac output (using the Fick principle) were 
performed. Cournand and Richards first began their classic studies of right-heart 
physiology in 1936. They catheterised the right ventricle in 1942 and the pulmonary 
artery in 1944 (7), and published a series of papers on simultaneous right-heart 
pressure measurements and oximetry-based studies of cardiac output. Cournand and 
Richards shared the Noble Prize in Physiology or Medicine in 1956 with Forssmann 
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for their work in the discovery of cardiac catheterisation and haemodynamic 
measurements. 
 
By the end of 1940s, right-heart catheterisation and its use in pressure recording, 
oximetry and angiography had become so advanced that the technique is little 
different today, except for the balloon-tipped catheters and advances in catheter 
materials. 
 
Left heart catheterisation 
Although early pioneers performed retrograde left-heart catheterisation in animals, the 
application of the technique to human followed numerous crude, daring and risky 
methods by advancing catheters into the left ventricle or left atrium by direct 
antegrade routes. The retrograde route was only applied much later. 
 
Reboul and Racine performed the first percutaneous ventricular needle puncture of 
both ventricles in dogs for the injection of contrast in 1933 (17). Rousthoi performed 
experimental retrograde left-heart catheterisation in animals in the same year using 
needle puncture of the aorta for access, but never performed left ventriculography 
(18).  Nuvoli duplicated the approach for the first time in a human in 1936, with fatal 
results (19). This direct aortic puncture technique later became the main method for 
aortic catheterisation although direct ventricular puncture technique persisted into the 
1950s, especially for patients with aortic stenosis. Farinas performed the first 
retrograde aortography in 1941 via femoral artery cutdown access (20). Direct needle 
access of the aorta was gradually abandoned in favour of retrograde catheterisation 
utilising the brachial, radial (21), ulnar (22) or femoral arteries, first by cutdown and 
 20 
later by percutaneous access. In 1953, Seldinger invented a technique for the 
percutaneous replacement of an access needle with catheters over the wires (23), 
which became widely applied for virtually all catheterisation techniques within the 
next decade, due to its simplicity and safety. 
 
Selective coronary angiography 
Nonselective opacification of the coronary arteries in patients undergoing ascending 
aortogram has been reported as early as in 1933 (18). Numerous ingenious yet 
cumbersome and ineffective methods for enhancing coronary opacification through 
the use of ascending aortic injections were devised. Such brute-force methods were 
however, clearly inadequate and hazardous.  
 
Mason Sones initiated the next revolution in invasive cardiology when he performed 
the first selective coronary angiography in 1958, by accident (24). After performing a 
left ventriculogram in a patient with valvular disease, Sones pulled the catheter back 
for an aortogram. He did not, however, verify the catheter position before proceeding 
and was horrified to find the catheter accidentally intubated the right coronary ostium 
during cine-angiography. Before he could pull the catheter out, 40 ml of contrast was 
injected directly into the right coronary artery. The patient went into asystole and 
Sones managed to resuscitate him via coughing, which converted the rhythm to sinus 
bradycardia (25). Sones soon developed the new technique of selective coronary 
angiography with specially formed catheters, by using brachial artery cutdown access. 
Diagnostic-grade coronary angiograms were now possible, opening the way to 
accurate diagnosis of coronary artery disease, laying the groundwork for future 
revascularisation therapy.  
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Although Ricketts and Abrams introduced new preformed polyethylene coronary 
catheters and a percutaneous femoral artery approach in 1962 (26), Sones technique 
remained the standard until 1967 when Judkins (27) and Amplatz (28) separately 
reported a more practical and advanced group of preformed catheters for percutaneous 
use via femoral artery access. The arrival of Judkins and Amplatz catheters 
revolutionised and facilitated an explosive growth in percutaneous catheterisation via 
the femoral artery access, and fostered the critical transition from diagnostic 
catheterisation to therapeutic intervention by catheter methods.   
 
Percutaneous coronary angioplasty 
 
Figure 3. First percutaneous transluminal angioplasty, performed by Dotter in 1964 
on left popliteal artery of an 82-year-old woman with gangrene who had refused 
amputation. Before (left), after (middle) and 2 years later (right). Patient’s leg was 
salvaged. (From Dotter CT. Radiology 1980;135:561-4.) 
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As is so frequently the case with important discoveries, the innovation of angioplasty 
was serendipitous. Such unexpected discovery, however, was immediately apparent to 
the operators. Opportunity thus favoured the prepared mind. In 1963, Dotter 
inadvertently recanalised an occluded right iliac artery by passing a percutaneous 
catheter retrogradely through the occlusion to perform an abdominal aortogram (29). 
The dawn of interventional era began. Dotter and Judkins went on to perform the first 
intentional transluminal angioplasty on an 82 year-old lady in 1964 (30), successfully 
curing her gangrenous left foot caused by popliteal artery stenosis (Figure 3). 
 
Building on Dotter and Judkins’ work and his own research involving balloon-tipped 
catheters, Andreas Gruentzig used his double-lumen balloon catheter with success in 
experimental and human peripheral angioplasty (31). By 1976, Gruentzig had 
miniaturised his double-lumen system for use in the coronary arteries (32). After 
successful animal studies followed by cadaver studies, he presented his experimental 
results at the American Heart Association in November 1976 which were met with 
scepticism and derision (33). Undeterred, Gruentzig went on to perform the first 
coronary angioplasty in an awake human in Zurich, on September 16, 1977 (34). The 
patient was a 37-year-old insurance salesperson (same age as Gruentzig at the time) 
with a focal proximal left anterior artery stenosis. The patient consented to 
angioplasty even after being informed that he would be the first person so treated. 
Gruentzig later published a report on his first five cases in a letter to the editor of 
Lancet in February 1978 (35). Of note, the insurance salesperson underwent 
surveillance cardiac catheterisation 1 month and 10 years after the initial procedure 
despite the lack of recurrent symptoms; there was no restenosis (Figure 4). 
Recognition of Gruentzig’s triumph was immediate and widespread. Unlike in 1964 
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and 1976, the medical community was ready to embrace percutaneous 
revascularisation, and the era of percutaneous coronary intervention (PCI) began.  
 
Figure 4. First percutaneous transluminal coronary angioplasty (PTCA) in a 
conscious patient. Left, right anterior oblique view of left anterior descending artery 
before PTCA on September 16, 1977. Right, same view of same patient’s artery 10 
years later on September 16, 1987 demonstrating persistent patency of dilated 
segment. (From Douglas JS et al. in Hurst JW. The heart. 7
th
 ed. New York:McGraw-
Hill, 1990)  
 
 
 
The unrelenting progress in interventional cardiology over the last thirty years has 
been breathtaking, with no sign of slowing down. From plain-old-balloon angioplasty 
to bare metal stenting and more recently to the drug eluting stent; from 9 French to 5 
French equipment; from single vessel to multi-vessel angioplasty and from 
angioplasty in stable patient to primary angioplasty for acute myocardial infarction. 
Not to mention the ever evolving new adjunct devices and new pharmacological 
agents to aid improve the results and outcomes of percutaneous coronary angioplasty. 
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Transradial catheterisation 
Transradial access appeared early in the development of cardiac catheterisation 
techniques with the first description of transradial central arterial catheterisation and 
attempts at coronary artery imaging using radial artery cutdown and 8 to 10 French 
catheters published by Radner in 1948 (21). Limitations of contemporary equipment 
resulted in the shift to larger vessels such as brachial and femoral arteries for most 
catheter based procedures. The radial artery has, however, been safely employed for 
many years for haemodynamic monitoring (36, 37). It is an attractive access site for 
cardiac procedures because of its favourable neurovascular anatomy. It has a 
superficial course of the wrist which facilitates percutaneous puncture, and overlies 
the forearm bones facilitating compression haemostasis. No major nerves or veins lie 
close to the radial artery, limiting the risk of neurological damage or arterio-venous 
fistula formation. The forearm and hand have a dual blood supply, with the ulnar 
artery limiting the risk of ischaemic complications if radial artery occlusion occurs as 
a consequence of the procedure. These advantages are offset by the relatively small 
calibre of the radial artery, which precluded its routine use for cardiac procedures 
when only large calibre catheterisation equipment was available between the late 
1950’s and mid 1980’s. 
 
In the late 1980’s and early 1990’s, advances in materials science and engineering 
technology facilitated the miniaturisation of catheterisation equipment, which was 
compatible with introduction into the relatively small calibre radial artery. These 
developments coincided with an explosive rise in the rate of femoral complications 
associated with the introduction of coronary stents and the use of multiple potent 
antiplatelet and anticoagulant agents. These two factors led cardiologists to evaluate 
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the use of the radial artery as an access site for diagnostic and therapeutic cardiac 
procedures.  
 
In the pursuit of minimising procedure related vascular complications, Lucien 
Campeau started exploring the feasibility of radial access coronary angiography using 
5 French catheters in October 1986. His first 30 patients were men with an apparent 
large radial artery, an easily palpable ulnar artery and a normal Allen’s test. This was 
followed by 70 consecutive patients of both genders with a normal Allen’s test, and 
reported the first series of diagnostic cardiac catheterisations performed via the radial 
artery in 1989 (38), reporting an overall success rate of 88%. Significant 
complications occurred in 2% (2 cases) comprising artery dissection and radial artery 
occlusion, both without symptoms of ischaemia of the hand.   
 
The radial approach for diagnostic coronary angiography was soon adopted by Otaki 
in Osaka, Japan, who reported his case series of 40 patients, in whom the femoral 
approach was difficult or contraindicated (39). Procedure failure occurred in 1 patient 
(3%) and there were no major complications.  
 
Kiemeneij and Laarmann reported the first transradial coronary interventional series 
in 1993 (40, 41), and are credited for popularising the transradial technique. Despite 
the observed reduction in peri-procedural bleeding and reported improvements in 
patient comfort, the transradial approach was only utilised by a few early adopters 
mainly in Asia and parts of Europe, and remained a niche technique for the next 
decade. 
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As experience with the transradial approach grew over the next decade, it was 
repeatedly demonstrated that the transradial approach has minimal severe vascular 
complications but with similar procedural success when compared to the transfemoral 
approach. A learning curve for developing proficiency in transradial procedures (42) 
as well as cost effectiveness (43-45) was noted in small observational studies. A series 
of randomised trials have compared radial and femoral access, with a recent meta-
analysis confirming that the radial approach reduces access site complications and is 
therefore safer (46).  
 
The first large scale transradial interventional programme in the UK was established 
at the University Hospital of North Staffordshire in 1998 (47). It also provided the 
unique opportunity of a transradial interventional fellowship programme at Onze 
Lieve Vrouwe Gasthuis, Amsterdam, under the guidance of Kiemeneij and Laarmann. 
Coupled with the development of transradial programmes in other centres in the UK, 
the radial approach has grown from under 1% to over 50% of all percutaneous 
coronary interventions (48).  
 
1.2 OVERVIEW OF ACCESS SITE ISSUES 
The arterial access site chosen for percutaneous cardiac procedures can have an 
important influence on procedural costs and procedural related morbidity and 
mortality. Access site complications can cause major disability and death. With the 
exponential rise in cardiac catheterisations and the use of multiple potent antiplatelet 
agents as standard practice during percutaneous coronary intervention, containing 
access site complications is an important clinical challenge. This section provides a 
brief overview of the access site issues related to the technically challenging brachial 
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cut-down approach, the preferred percutaneous Seldinger femoral approach and the 
transradial approach. 
 
Comparison of arterial access sites complications  
Brachial artery access route  
When a surgical cut down approach to the brachial artery is employed for cardiac 
procedures, operator skill and experience are important factors in limiting the rate of 
complications associated with this technically demanding approach. Skilled high 
volume operators can achieve low complication rates even in the setting of intensive 
antithrombotic therapy (49). For less skilled or infrequent operators, most series 
consistently reported a 5-10% incidence of major complications (50-54) (Figure 5). 
Major neurovascular complications resulting in acute arm ischaemia or median nerve 
palsy occur in around 5% of patients (Figure 6). An alternative method to this 
approach employs a percutaneous Seldinger technique to position a sheath in the 
brachial artery. This technique is technically much simpler than a surgical cut down, 
but is associated with a similar risk of important neurovascular complications (55). 
Because of these issues brachial access is now rarely employed. 
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Figure 5. Neurovascular complications after brachial artery cut-down procedures. 
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Figure 6. Median nerve palsy following coronary angiography via the brachial artery. 
 
 
 
 
Femoral artery access route  
Percutaneous femoral approach catheterisation revolutionised the practice of invasive 
cardiology following the introduction of the Seldinnger technique and remains the 
access of choice in many institutions (56). The femoral approach facilitates rapid and 
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simple access to the left side of the heart and usually facilitates good catheter support 
as well as access to large-diameter devices. Such advantages are partially offset by 
bleeding complications, often mandating prolonged bed rest and further treatment 
(including compression or thrombin injection for a pseudoaneurysm, blood 
transfusion or surgical intervention) (Figure 7 & 8). These can lead to further 
discomfort and a longer hospital stay, consuming additional institutional resources. In 
a minority of patients femoral vascular complications can be severe and lead to death. 
The incidence of significant neurovascular complications ranges from 1% following a 
simple diagnostic procedure to 17% when large bore catheters are employed in 
association with aggressive antithrombotic therapy in PCI (Figure 9) (57-61). One-
third of patients who sustain an iatrogenic femoral nerve injury related to a cardiac 
procedure have a permanent neurological deficit (62). Concealed retroperitoneal 
bleeding, although uncommon, is an ominous complication that has a reported 
mortality rate of 15% (63).  
 
Figure 7. Large femoral haematoma post femoral cardiac catheterisation. 
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Figure 8. Pseudoaneurysm post femoral access cardiac catheterization. 
 
 
 
Figure 9. Femoral access site complications in current practice. 
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Indeed there may be a relationship between major bleeding after PCI and increased 
risk of long term mortality, as reported in subgroup analysis of many trials and 
registries (64-67).  Kuchulakanti et al retrospectively analysed 10669 patients treated 
by PCI over a seven year period and reported an incidence of vascular complications 
post PCI of 10.3% (66). Their main finding was that patients with vascular 
complications post PCI had a significantly higher incidence of in-hospital 
complications including death, myocardial infarction and coronary artery bypass 
grafting compared to patients without vascular complications. They also had 
 31 
significantly higher incidence of non-Q wave myocardial infarction and mortality at 1 
year. Reduction of vascular access site complications is therefore a critical challenge 
in PCI procedures. 
 
A meta-analysis of 10 observational studies involving 133,597 patients with acute 
coronary syndromes confirmed that major bleeding is a strong predictor of in-hospital 
and 30-day death and acute myocardial infarction (68). Bleeding was associated with 
7-fold and 3-fold increase in 30-day death and myocardial infarction respectively. Rao 
et al also demonstrated that patients with acute coronary syndromes who developed 
anaemia during hospital admission and required transfusion had a more than 3-fold 
increase in the risk of death and myocardial infarction at 30-day (69). 
 
The MORTAL study retrospectively examined the association between access site, 
transfusion, and outcomes in over 32,000 patients who underwent PCI in British 
Columbia, Canada from 1999 to 2005 (67). The main finding showed that vascular 
access site complications was significantly reduced with the use of the radial access 
site, which was associated with a 50% reduction in transfusion rate and a relative 
reduction in 30-day and 1-year mortality of 29% and 17%, respectively (P<0.001).  
 
Although all these studies were observational, they nonetheless convey important 
messages for practicing interventional cardiologists suggesting that access site 
complications, major bleeding and transfusion are prognostic predictors of patient’s 
outcome. Reduction of such complications is therefore a critical challenge.  
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Numerous vascular closure devices have been developed in recent years to obtain an 
efficient arteriotomy closure immediately at the end of the procedure. Evidence based 
data supporting the use of these vascular closure devices are disappointing and meta-
analysis of 30 randomised trials (with a total sample size in excess of 40000 patients) 
concluded that vascular closure device is only marginally more effective than 
standard manual compression in the setting of diagnostic CA, and may increase the 
risk of haematoma and pseudoaneurysm in the setting of PCI (70, 71). In addition to 
these complications, access via a brachial or femoral access site is impossible in 5–
10% of patients, due to anatomical variation, peripheral vascular disease or obesity, 
and the radial access site may allow such patients to be investigated and treated. 
 
Radial artery access route 
Multiple studies have compared the radial approach with femoral or brachial access. 
The best known study, the Access Trial (72) examined the relative merits of the 
percutaneous brachial, femoral and radial access sites in 900 patients undergoing 
elective PCI. It demonstrates that the radial approach is the safest, with no significant 
vascular complications occurring, compared to rates of 2% in the femoral group and 
2.3% in the brachial group. There was no increase in total procedure duration or 
radiation exposure when transradial procedures were compared with percutaneous 
femoral procedures. A meta-analysis of 12 randomized control trials by Agostoni et al 
(which includes the Access Trial) further confirmed that the transradial approach is a 
highly safe technique with comparable procedural duration, radiation exposure and 
clinical results to that of the transfemoral approach (46). More importantly, vascular 
access site complications are virtually abolished (0.3%) by the transradial approach.  
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Given the demonstrated reduction in the risk of vascular complications, the radial 
artery is a particularly attractive option in the setting of anticoagulation, post 
thrombolysis or aggressive antiplatelet therapy. Hildick-Smith et al reported low rate 
of radial access complications in fully anticoagulated patients with INR > 2 who had 
transradial coronary angiography (73). In a comparison of vascular access site 
complications in patients undergoing PCI with adjunctive intravenous GP IIbIIIa 
inhibitor therapy, 7.4% of the transfemoral patients had a major vascular access site 
complication (despite the use of weight adjusted heparin, small calibre guiding 
catheters and femoral artery closure devices in the majority of these patients), 
compared to none of the similarly treated radial patients (74). In the setting of rescue 
PCI with adjunct GP IIbIIIa inhibitor, the reported rate of major femoral vascular 
complications ranges from 20-39% (75-78) and around 10% even if vascular closure 
devices are employed (79). Emerging data assessing the efficacy of transradial PCI in 
such setting have all reported near complete elimination of vascular complications 
and with comparable procedural success rate as the transfemoral approach (80).
   
 
 
Other related issues 
Patient comfort and preference are also important considerations in the comparison of 
these access sites. Delayed mobilisation after transfemoral procedures is common, due 
to inguinal pain, while bed rest itself has been shown to have an adverse effect on 
outcome (81, 82).
 
Patients undergoing elective transradial PCI can be mobilised 
immediately after the completion of these procedures with no adverse effects or risks, 
which allows PCI to be performed on a day case basis (83, 84). Coronary angiography 
via the radial artery as opposed to the femoral artery is associated with short-term 
improvements in quality of life, whilst at the same time reducing hospital costs (44, 
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85). The radial approach for intervention was preferred by 73% of patients in whom 
preceding diagnostic films were acquired by the femoral route (86). As a result of the 
shorter hospital stay and reduced complication rates associated with transradial 
procedures, hospital costs of coronary stent deployment can be reduced by 15% when 
compared with the femoral route (44).  
 
Although the transradial technique fulfills the requirements for a safer access site for 
interventional procedures with the added advantages of cost savings and improved 
quality of life, the transfemoral approach remains the preferred technique for most 
cardiologists. This is to a large extent due to the significant learning curve associated 
with the transradial technique (which ranges from radial artery puncture failure, 
radial artery spasm to catheter manipulation difficulties especially in relation to 
upper limb arterial anatomical variations), even for experienced femoral operators, as 
well as concerns regarding higher radiation exposure to both the operators and the 
patients. There is also a general misconception that with improvement in technology 
and equipment used, femoral access site vascular complications have become 
infrequent. 
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1.3 AIM OF THE THESIS 
The aim of this thesis is to evaluate upper limb arterial anatomy and function, 
procedural technique and clinical applications of the transradial access site in relation 
to invasive cardiac procedures.  
 
HYPOTHESES TO BE TESTED 
1. There is a reduction in vascular complications in transradial compared to 
transfemoral cardiac procedures. 
2. Radial artery anatomical variation influences the outcome of transradial 
cardiac procedure and complications.  
3. Radial artery diameter vary in relation to age, sex, height, hand dominance, 
smoking, the presence of certain disease subgroups (hypertension, chronic 
renal failure, diabetes mellitus and peripheral vascular disease) and Glyceryl 
Trinitrate. 
4. There is no difference in radiation exposure in transradial and transfemoral 
coronary angiography when performed by experienced radial and femoral 
operators respectively. 
5. Radial access can be applied to high risk patient subsets with minimal vascular 
complications. 
 
PLANS 
This research study is subdivided into six projects:- 
Project 1 – Vascular complications study.  
 Project 2 – Radial artery anatomical variation study.  
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 Project 3 – Study of radial artery diameter and the effect of GTN on radial   
artery. 
 Project 4 – Comparison of radiation exposure in transradial and transfemoral 
diagnostic coronary angiography 
 Project 5 – Transradial rescue percutaneous coronary intervention. 
 Project 6 – Percutaneous left and right heart catheterisation in fully 
anticoagulated patients using the arm approach.  
 
The following chapters discuss the theoretical background to the methods used to 
evaluate the above objectives. There then follow sequential chapters detailing and 
discussing studies investigating vascular complications, radial artery anatomy and 
function, procedural technique and clinical applications of the transradial access site 
in relation to invasive cardiac procedures, followed by final chapter summarising the 
results and discussing implications and future directions.  
 
Overall, such in-depth information may help shorten the learning curve and optimise 
transradial procedure technique with improve outcome, and thereby help drive the 
adoption of transradial approach. It should also help to extend the use of the radial 
access site into high-risk patient subgroups. 
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CHAPTER 2 
 
ACCESS SITE COMPLICATIONS 
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2.1 INTRODUCTION 
Femoral arterial puncture is the most common method of vascular access for coronary 
angiography (CA) and percutaneous coronary intervention (PCI). Peri-procedural 
bleeding complications as a result of PCI are common and occur in up to 5% of cases 
performed in patients presenting with acute coronary syndromes (ACS). A substantial 
proportion of the bleeding occurs at the vascular access site (87-91). Such 
complications are not insignificant as findings from observational studies indicate that 
major bleeding is associated with an increased risk of recurrent ischaemic events and 
death (92, 93). Indeed, a femoral haematoma requiring transfusion is an independent 
predictor of 1-year mortality (94). 
 
Strategies to reduce bleeding include improved puncture technique, more individual 
tailored and monitored anticoagulant and antiplatelet treatments and alternative 
arterial access. Vascular access via the radial artery, a superficial and easily 
compressible artery, has been shown to reduce risk of access site bleeding and other 
vascular complications in meta-analysis of randomised trials (46, 95). Transradial 
access is, however, a technically more demanding technique and coupled with a 
natural resistance to change, this has made the use of this approach still a minority 
worldwide. Furthermore, there is also a general misconception that with 
improvement in technology and equipment used, femoral access site vascular 
complications have become less frequent although anecdotal experience suggests 
that many of these complications may be under-reported (58). 
 
This primary aim of this study was to investigate the rate and extent of vascular 
complications between the transradial and transfemoral routes in patients undergoing 
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CA and PCI, in ‘contemporary real world’ practice. The secondary aim was to assess 
the impact on length of in-patient stay as a result of these complications and the 
efficacy between the Radi-Stop  and the TR Band  transradial compression devices.  
 
2.2 METHODS 
Study Subjects 
All patients undergoing elective, urgent or emergency cardiac catheterisations in the 
Cardiology Department of University of North Staffordshire were prospectively 
studied over a 3-month period from 8
th
 January to 7
th
 April 2007. One thousand and 
fourteen consecutive patients were recruited over this period. Patients were admitted 
to the cardiac catheter laboratory per indications and the procedures performed as per 
standard protocol. The choice of arterial access was selected as per operator skill and 
preference. 
 
Data collection 
A 2-side study sheet was attached to the patient’s admission note (Attachment 1) and 
was prospectively completed by clinical staff members during a 3-month period. 
Patient demographics, procedure details, post procedural haemostasis care, any 
vascular complications and patient outcome were collected. 
 
Access site haemostasis was assessed by trained nursing staff and any vascular 
complications recorded on the data sheet. These were later verified by research team. 
A haematoma was defined as any swelling around the arterial puncture site and was 
categorised as being >5cm or < 5cm. Bleeding events were classified according to the 
Global Utilisation of Streptokinase and Tissue Plasminogen Activator for Occluded  
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Coronary Arteries criteria (96). Severe bleeding is defined as a substantial 
haemodynamic compromise, moderate bleeding by the need of transfusion and minor 
bleeding as neither requiring transfusion nor resulting in haemodynamic instability. 
 
Statistical analysis 
Statistical analysis was performed using IBM SPSS Statistics 19.0 (IBM Corp., 
Armonk, New York, USA). The distribution of continuous data was determined using 
the 1-sample Kolmogorov-Smirnov test. Categorical data were presented as absolute 
values and percentages whereas continuous data were presented as mean ± standard 
deviation. Student’s t test and Mann-Whitney U test were used to compare continuous 
data as appropriate. Categorical data were compared using the Chi-Square test with 
the appropriate degree of freedom. A p value of less than 0.05 was considered to be 
statistically significant. 
 
2.3 RESULTS 
Patients and procedural characteristics 
A total of 1014 patients were studied, comprising 405 patients from the transradial 
group and 609 patients from the transfemoral group, with a mean age of 62.3±10.9 
and 62.5±11.0 respectively (Table 1). Just over 50% of the transradial group of 
patients had the procedures done electively compared to 63% of the transfemoral 
group. Fifty-five and sixty-one per cent of the transradial and the transfemoral groups 
underwent PCI respectively. Procedures were done using 5 French and 6 French 
systems apart from 6 patients (1%) from the femoral group where 7 French systems 
were used. 
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Table 1. Patient and procedural characteristics. -overall 
* LOS = length of stay 
 
Seven patients (4.5%) had an unsuccessful radial procedure as a result of failed 
puncture (2 patients), radial artery spasm (4 patients) and radial artery dissection (1 
patient). These patients had their procedure completed using the femoral route. There 
was no access site cross over from the femoral group. 
 RA 
(n=405) 
FA 
(n=609) 
P value 
Age  62.3±10.9 62.5±11.0 NS 
Male (%) 73 64 NS 
BMI 28.7±6.1 28.2±5.0 NS 
Diabetes (%) 15% 11% NS 
Renal Impairment (%) 5% 7% NS 
Peripheral vascular disease (%) 4% 5% NS 
Drugs (%)    
Aspirin 81.0 % 85.1 % NS 
Clopidogrel 29.9 % 31.0% NS 
Unfractionated Heparin 100 55.0% <0.0001 
Glycoprotein IIbIIa inhibitor 21.0% 19.9% NS 
Thrombolytic agent 1.2% 1.0% NS 
Warfarin 5.2% 0% <0.005 
5F:6F:7F (%) 30:70:0 1:97:2 N/A 
Angio (%) 39 45 NS  
PCI (%) 28 25 NS 
Adhoc PCI (%) 33 30 NS 
Procedure duration (mins) 41.7±25.5 37.8±27.6 0.03 
Elective:Urgent:Emergency 
(%) 
53:39:8 63:31:6 N/A 
Vascular complications, n(%) 36 (8.9) 98 (16.1) 0.002 
Small haematoma, n(%) 24 (5.9) 61 (10.0) 0.029 
Large haematoma, n(%) 5 (1.2) 24 (3.9) 0.014 
Others minor complications 7 (1.7) 13 (2.1%) 0.161 
Transfusion, n (%) 0 1 0.576 
Vascular intervention 0 1 0.576 
Total additional LOS
*
 (days)
 
5 (1-3) 63 (1-9) 0.006 
Average additional LOS
*
 
(days)  
1.67 2.4 NS 
Angioseal 0 39 (6.4%) N/A 
Angioseal related vascular 
complications 
0 3 (7.7%) N/A 
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Procedure duration was statistically longer with the transradial procedures than the 
transfemoral procedures. However the time used to remove the femoral sheath and the 
time to ambulation was not taken into consideration, as this would significantly 
increase the overall transfemoral procedure duration. 
 
Access site and vascular complications 
Ninety-eight vascular complications (16.1%) were observed in all transfemoral 
procedure compared to 36 (8.9%) in the transradial group, p=0.002 (Table 2). Of 
these, 61 (10.0%) were small femoral haematoma and 24 (3.9%) large femoral 
haematoma. Although diagnostic angiography performed via the transfemoral 
approach did not appear to be associated with statistically significant small 
haematoma compared to transradial approach, the risk of large femoral haematoma 
remains unacceptably high (Table 3). Transfemoral PCI, especially if performed in 
the context of acute coronary syndrome or unstable patients was associated with 
significantly higher risk of vascular complications (Table 4). Use of vascular closure 
device was also associated with a relatively high rate of vascular complications. 
 
No deaths occurred during the study period. There was one moderate femoral 
bleeding post PCI for unstable angina requiring 2 units of transfusion.  One large 
femoral haematoma required thrombin injection as it did not respond to prolonged 
external compression. Overall, an additional 63 days were spent in the hospital as a 
result of femoral access site complications compared to 5 additional days for radial 
access site complications, p=0.006.  
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Table 2. Vascular complications and access site selection. 
 RA 
(N=405) 
FA 
(n=609) 
P value 
Small haematoma, 
n (%) 
38 (5.9%) 61 (10.0%) 0.029 
Large haematoma, 
n (%) 
5 (1.2%) 24 (3.9%) 0.14 
Other minor 
complications 
7 (1.7%) 13 (2.1%) 0.161 
Overall 
complications 
36 (8.9%) 98 (16.1%) 0.002 
Transfusion 0 1 (0.7%) 0.576 
Vascular 
intervention  
0 1 (0.7%) 0.576 
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Table 3. Characteristics of patients who underwent diagnostic angiography. 
* LOS = length of stay 
 
 
 
 
 
 
 
 
 
 
 
 
 RA 
(n=157) 
FA 
(n=272) 
P value 
Age  63.2±11.2 61.7±11.3 NS 
Male (%) 69 62 <0.05 
BMI 29.1±6.4 28.4±5.1 NS 
Diabetes (%) 17 10 NS 
5F:6F:7F (%)   N/A 
Elective:Urgent: (%) 78:22 87:13 N/A 
Single: Multiple Puncture 
(%) 
89:11 95:5  
Access site cross over (%) 7 (4.5%) 0 0.001 
Vascular complications, n(%) 13 (8.2) 34 (12.5) 0.016 
Small haematoma, n(%) 10 (6.4) 19 (7.0) 0.195 
Large haematoma, n(%) 2 (1.3) 11 (4.1) 0.005 
Others 1 (0.6) 4 (1.5%) 0.529 
Procedure duration (mins) 42.6±24.6 37.2±29.3 0.03 
Total additional LOS
*
 (days)
 
1 25 <0.0001 
Average additional LOS
*
 
(days) 
1 2.2 NS 
Angioseal 0 11 (4.1%) N/A 
Angioseal related vascular 
complications 
0 1 (9.1%) N/A 
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Table 4. Characteristics of patients that underwent PCI. 
* LOS = length of stay 
 
Radial access and vascular complications 
Just fewer than 40% of all procedures were done via the transradial approach during 
the study period. The compression devices used during the study period were Radi-
Stop  (Figure 10) and the TR Band  9figure 11) and these were analysed separately 
to assess the efficacy of the devices (Table 5). The ratio of usage of Radi-Stop  to the 
TR Band was 1.9:1. There were more male patients in the Radi-Stop  group than 
the TR Band  group. The TR band appeared to be associated with a higher rate of 
minor vascular complications including small haematoma but there was no difference 
in the rate of large haematoma. 
 
 
 RA 
(n=248) 
FA 
(n=337) 
P value 
Age  61.8±10.7 63.1±10.8 NS 
Male (%) 75 66 <0.05 
BMI 28.5±5.8 28.1±4.9 NS 
Diabetes (%) 15 11 NS 
5F:6F:7F (%) 20:80:0 1:98:1 N/A 
Elective:Urgent:Emergency 
(%) 
53:39:8 63:31:6 N/A 
Single:Multiple puncture 91:9 90:10 NS 
Access site cross over 0 0 N/A 
Vascular complications, n(%) 23 (9.3) 64 (19.0) <0.0001 
Small haematoma, n(%) 15 (6.1) 44 (13.1) 0.002 
Large haematoma, n(%) 3 (1.2) 13 (3.9) 0.03 
Others 5 (2.0) 7 (2.1%) 0.743 
Procedure duration (mins) 41.1±26.1 38.3±26.1 0.035 
Total additional LOS
* 
(days)
 
4 (1-3) 38 (1-9) <0.0001 
Average additional LOS
*
 
(days) 
2 2.6 NS 
Angioseal 0 28 (8.3%) N/A 
Angioseal Vasc Comp 0 2 (7.1%) N/A 
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Table 5. Patient characteristics for Radi-Stop  Vs TR Band  
* LOS = length of stay 
 
Figure 10. Radi-Stop   
 
 
 RADI 
(n=266) 
TR Band 
(n=139) 
P value 
Age  61.1±10.9 64.7±10.7 NS 
Male (%) 84 52 0.005 
BMI 29.3±6.1 27.5±5.8 NS 
Diabetes (%) 16 14 NS 
5F:6F (%) 24:76 42:58 N/A 
Elective:Urgent:Emergency 
(%) 
58:36:6 45:45:10 N/A 
Vascular complications, n(%) 14 (5.3) 22 (15.8) 0.0001 
Small haematoma , n (%) 11 (4.2) 13 (9.3) 0.003 
Large haematoma, n (%) 2 (0.8) 3 (2.1) 0.079 
Others, n (%) 3 (1.1) 4 (2.9) NS 
Angio (%) 38 42 NS 
PCI (%) 62 58 NS 
Procedure duration (mins) 43.4±26.1 41.3±24.1 NS 
Total additional LOS
* 
(days)
 
2 3 NS 
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Figure 11. TR Band  
 
 
 
2.4 DISCUSSION 
Numerous studies have previously demonstrated that access site bleeding 
complications are high for both transfemoral CA and PCI (97-101). In addition, 
patients who had a femoral procedure also experienced more groin pain, longer 
periods of bed rest and hospital stay. Other studies compared complication rates after 
TR Band  
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CA or PCI performed with either transfemoral or transradial access and concluded 
that radial access is safer with significantly lower risk of vascular complications (44, 
47, 102). 
 
Access site bleeding complications remain the commonest non-cardiac complication 
following a percutaneous cardiac procedure (103, 104). Our study confirms that 
access site vascular complications via the femoral artery remain unacceptably high at 
16.1%. Although neither death nor severe bleeding occurred in this study period, such 
complications could lead to prolongation of hospital admissions.  
 
Indeed, the observed additional 63 days spent in hospital as a result of vascular 
complications in our study are a financial burden to the healthcare system. The cost 
could rise even more considerably in the event of a fatal or severe bleeding episode, 
which have also been shown to be an independent predictor of mortality, reinfarction 
and stroke (69, 91, 92, 105). Our data indicate that a substantial amount of hospital 
expenditure through prolonged admission and related cost may arise because of these 
complications. 
 
Overall incidence of radial vascular complications in our study was relatively high at 
8.9%. This was driven by small haematoma and other minor vascular complications. 
The incidence of large haematoma complication was low at 1.2%. An additional 5 
days was spent in hospital as a result of radial access site complications thereby 
giving a net 58 days saved compared to femoral access site related vascular 
complications.  
 
 49 
An unexpected finding was that the TR Band was associated with a higher rate of 
small haematoma formation than the RadiStop. This was likely related to the fact that 
the TR band does not immobilise the wrist. It does, however, have the advantage of 
allowing for accurate gradual deflation of compression on the wrist. Both types of 
devices are designed to have unilateral compression of the radial artery, hence 
avoiding venous congestion of the forearm, reducing the potential risk of an upper 
arm deep vein thrombosis (106). There are newer dedicated radial compression 
devices that are now available in the market which may further improve the efficacy 
of radial access site haemostatic management. 
 
In summary, transfemoral access site bleeding complications remain unacceptably 
high in contemporary practice. Transradial access can reduce such risk, especially 
access site related major bleeding complications, resulting in better patient outcome 
and much lower additional length of stay in hospital. The transradial access should 
therefore be the access site of choice. 
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Attachment 1 
 
Assessment of Vascular Complications UHNS 2007  
 
A. Patient Details 
Name:                                Hospital No:       Age:  
 
Sex: F  ⁪  M  ⁪        Ht:        Wt:                        BMI:   
 
Date of Admission:         Date of discharge: 
 
Medications:    
Aspirin    ⁪  Unfractionated Heparin  ⁪ 
Clopidogrel    ⁪ GP IIb/IIIa inhibitor   ⁪ 
LMWH    ⁪ Thrombolytic agent  ⁪ 
Warfarin/other anticoagulant ⁪ INR:      
 
B. Procedure Details 
Date of Procedure:     Operator: 
 
Indications: 
Diagnostic⁪    Stable angina⁪    ACS⁪    TnT +ive ACS⁪    STEMI⁪ 
Failed reperfusion⁪    Valvular disease⁪    PFO/ASD⁪    HF aetiology⁪ 
Others: 
 
Case:                          Elective       ⁪   Urgent         ⁪    Emergency  ⁪ 
 
Types of Procedure:  LHC            ⁪   PCI                ⁪    LHC+RHC  ⁪            
                            Ad hoc PCI  ⁪   Rescue PCI   ⁪    IABP           ⁪ 
      Others:  
 
Routes of Procedure:  RFA⁪      LFA⁪      RRA⁪      LRA⁪ 
        
Numbers of Puncture: Single ⁪ Multiple ⁪ 
 
Sheath:  5F⁪    6F⁪    7F⁪ 
  
Use of intra-procedure anticoagulant:   
Heparin:  2500U⁪      5000U⁪      7500U⁪      10000U⁪ 
GP IIb/IIIa inhibitor              ⁪  
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C. Post Procedure Care 
 
ACT: 
 
Methods of Haemostasis: 
Manual pressure   ⁪            Angioseal     ⁪ Fem Stop          ⁪ 
Radi-Stop ⁪            TR Band       ⁪          Radial D-Stat    ⁪ 
 
Areas in which post procedure care is provided: 
Recovery area in Lab ⁪ Ward 76   ⁪ 
MAU    ⁪ Others   ⁪ 
 
D. Vascular Complications 
 
Complication: Yes  ⁪ No ⁪ 
  
If yes, types of complication: 
Vagal episode  ⁪  Haematoma < 5cm  ⁪ 
Haematoma > 5cm  ⁪  Pseudoaneurysm  ⁪  
AV fistula    ⁪  Retroperitoneal bleed ⁪ 
Groin pain   ⁪  Wrist pain   ⁪ 
Minor bleeding  ⁪  Major bleeding  ⁪ 
Severe bleeding  ⁪  Limb ischaemia   ⁪ 
Others: 
 
Onset of haematoma: 
Catheter laboratory ⁪  Before sheath removal ⁪ 
During sheath removal ⁪  After sheath removal ⁪ 
Unknown   ⁪ 
 
Intervention required for complications: 
Out patient Observation ⁪  In patient Observation ⁪ 
Ultrasound Scan  ⁪  CT Scan   ⁪ 
Transfusion   ⁪  Radiologist intervention ⁪ 
Surgical review  ⁪  Vascular surgery  ⁪ 
 
Additional length of stay: 
Number of days: __________________ 
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CHAPTER 3 
 
RADIAL ARTERY ANATOMICAL VARIATION AND ITS INFLUENCE  
ON TRANSRADIAL CORONARY PROCEDURAL OUTCOME 
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3.1 INTRODUCTION 
 
Since its initial description as a safe and feasible access route for cardiac 
catheterisation(38, 40) the radial artery has been increasingly used for percutaneous 
coronary procedures. The main advantage over the femoral artery is a reduced risk of 
vascular complications, particularly in the presence of multiple antiplatelet and 
antithrombotic agents (46, 72-74, 80, 107, 108). This is attributed to the favourable 
neurovascular anatomy of the radial artery where it runs superficially, separated from 
major nerves. Immediate ambulation and facilitation of day case intervention also 
favour the radial approach (44, 83-85). The transradial technique is, however, 
associated with a significant learning curve even for experienced femoral operators 
(42, 109-111). Anecdotal evidence suggests that once the learning curve is passed, 
most transradial procedure failures are due to anatomical variations but there are 
currently limited data on such information (112). We therefore undertook to establish 
the frequency of radial artery anomalies from radius to the radio-brachial anastomosis 
and their relation to procedure outcome in patients undergoing a first transradial 
coronary procedure. 
 
3.2 METHODS 
Study population 
This was a multicentre prospective study involving four tertiary centres in the UK: - 
University Hospital of North Staffordshire [UHNS], Brighton and Sussex University 
Hospital [BSUH], Freeman Hospital and Newcastle University [FHNU] and 
Manchester Heart Centre [MHC]. A total of 1540 patients undergoing their first 
transradial coronary procedure were recruited from January 2006 to June 2007. Four 
hundred and fifty five patients were recruited from UHNS, six hundred and thirty four 
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patients from BSHU, three hundred and fifty five patients from FHNU and ninety six 
patients from MHC. Only patients undergoing diagnostic angiography and coronary 
intervention were studied. Procedures were performed or supervised by experienced 
high volume radial operators (personal experience of >1000 cases). Patients with a 
previous transradial procedure were excluded. 
 
Radial artery cannulation 
Radial artery puncture was performed with a dedicated radial cannulation needle and 
guidewire according to operator preference. A short hydrophilic sheath (11cm) was 
inserted and an arterial vasodilator (containing 200-400µg isosorbide dinitrate and 
2.5-5.0mg of verapamil) given according to local protocols. Heparin (2,500–5,000 iu.) 
was given either as part of the vasodilator cocktail or in the aortic root. 
 
Retrograde radial arteriography 
Retrograde radial arteriography was performed following administration of the 
arterial vasodilator to define radial artery anatomy from mid-radius to radio-brachial 
anastomosis. A solution of 3mls of contrast mixed with 7mls of blood (to dilute the 
contrast and minimise any discomfort from contrast injection) was injected briskly 
through the side arm of the sheath with radiographic acquisition at the elbow in an 
anteroposterior projection. If a high-bifurcating radial origin was identified, a further 
arteriogram was obtained higher up the arm to identify the point of anastomosis to the 
brachial artery. 
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Transradial coronary procedures 
Retrograde radial arteriography was performed prior to coronary intubation in all 
patients. In patients who had a failed transradial puncture, it was at the discretion of 
the operator to attempt the contralateral radial artery or use the transfemoral approach. 
The arterial sheath was removed immediately after completion of the transradial 
procedure and haemostasis achieved using a unilateral radial compression system 
(RADI-Stop®, RADI Medical Systems, Uppsala, Sweden or TR Band™, Terumo 
Medical Corporation, Tokyo, Japan).  
 
Classifications and Definitions 
Forearm arterial patterns with clinical relevance to transradial cardiac catheterisation 
were classified using a modification of McCormack’s, Uglietta’s and Rodriguez-
Niedenfuhr’s definitions [Table 6] (113-115).  
 
Table 6. Modified classifications of forearm arterial patterns 
1. Normal anatomy 
 
2 High-bifurcating radial origin, rejoins at 
 
a. Lower third of humerus 
 
b. Middle third of humerus 
 
c. Upper third of humerus 
 
d. Axillary 
 
3 Radial loop with recurrent radial artery 
 
4 Extreme radial artery tortuousity 
 
5 Others  
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The site of anomalous origin was determined with reference to the intercondylar line 
of the humerus, which is a fixed line representing the proximal border of the 
antecubital fossa. Bifurcation of the brachial artery proximal to this line is considered 
a variant pattern. A high-bifurcating origin was further sub-classified into lower third 
of humerus, middle third of humerus, upper third of humerus or axillary according to 
the site of anastomosis with the main vessel. High-bifurcating radial artery calibre 
was also categorised as <2.0mm, 2.0-2.5mm, 2.5-3.0mm and >3.0mm by visual 
comparison with the arterial sheath.  
 
A radial artery loop was defined as the presence of a full 360º loop of the radial artery 
distal to the bifurcation of the brachial artery.  Extreme radial tortuosity was defined 
as the presence of a bend of more than 90º in the contour of the vessel. Anatomical 
variations that did not fit into these specified categories were grouped together and 
categorised as “other” anomalies.   
 
Procedural duration was defined as time interval elapsed from when the patient 
entered to when they left the catheterisation laboratory. Procedural success was 
defined as completion of the planned procedure via the initially selected radial access 
route. Minor vascular complications were defined as haematoma <5cm, vessel 
dissection without ensuing ischaemia, pseudoaneurysm and localised infection. Major 
vascular complications were defined as haematoma >5cm, any access site 
complications that required surgical or radiological intervention, >3gm/dl 
haemoglobin drop due to access site bleeding, bleeding requiring transfusion, limb 
ischaemia and/or compartment syndrome. 
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Data collection 
Patient demographics, procedural data, and radial arteriography findings with specific 
details of any anomalies and local vascular complications were collected on a 
specifically written data management database (PATS Dendrite). 
  
Statistical analysis 
Statistical analysis was performed using SPSS 19.0 (IBM Corp., Armonk, New York, 
USA). Categorical data were presented as absolute values and percentages whereas 
continuous data were presented as mean ± standard deviation. The nature of 
distribution of the data was determined using 1-sample Kolmogorov-Smirnov test. 
Student’s t test and Mann-Whitney U test were used to compare continuous data as 
appropriate. Categorical data were compared using the Chi-Square test with the 
appropriate degree of freedom. Both univariate and multivariate regression analysis 
were used to examine potential correlation between radial artery anomaly and 
variables such as sex, age, hypertension, diabetes and peripheral vascular disease. A p 
value of less than 0.05 was considered to be statistically significant. 
 
3.3 RESULTS 
Patients and procedural characteristics 
A total of 1540 patients were studied with mean age 63.6±11.1 years and 70.6% male.  
Baseline patient and procedural data are summarised on Table 7. Diagnostic coronary 
angiography was performed in 32.8%. Most procedures were attempted via the right 
radial artery and over 50% of procedures were performed using 5F sheaths and 
catheters. Transradial procedural success was 96.8% with 2.9% of patients requiring 
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femoral access for procedure completion. Procedures were abandoned in 0.3% (5 
cases). 
 
 
Table 7. Baseline clinical and procedural characteristics 
 
Clinical characteristics No. of patients (n=1540) % 
Age in years (range) 63.6±11.1 (24-90)  
Male : Female 1088 : 452 70.6 : 29.4 
Any of the following risk factors 1003 65.1 
   Hypertension 662 43.0 
   Diabetes 345 22.4 
   Peripheral vascular disease 135 8.8 
   Previous cardiac surgery 68 4.4 
Types of procedure   
    Diagnostic angiography 505 32.8 
    Ad hoc PCI 590 38.3 
    Elective PCI 445 28.9 
Procedural characteristics   
Access attempted  
    Right radial : Left radial    
 
1432 : 108 
 
93 : 7 
RA puncture failure 7 0.5 
Procedural success 1490 96.8% 
Sheath gauge 5F : 6F : 7F 780 : 739 : 21 50.6 : 48.0 : 1.4 
Procedure duration (min)   
    Diagnostic angiography 30.3±15.21 NA 
    Ad hoc PCI 48.4±21.4 NA 
    Elective PCI 47.4±22.2 NA 
Fluoroscopy time (min)   
    Diagnostic angiography 6.0±5.3 NA 
    Ad hoc PCI 11.1±7.5 NA 
    Elective PCI 11.8±8.6 NA 
Vascular complications   
    Minor 13 0.9 
    Major 2 0.1 
Data in number, mean±SD and percentage.  
PCI: percutaneous coronary intervention 
 
Radial artery anatomy and procedural outcome 
There were 7 cases (0.5%) of radial puncture failure. Retrograde radial arteriography 
was obtained in 1533 patients. Anomalies were noted in 212 (13.8%) and these 
patients were significantly older (mean age 67.1 years versus 64, p<0.001) more 
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commonly female (36% versus 28%, p=0.02) with significantly higher procedure 
failure rates (14.2% versus 0.9%, p<0.0001) [Figure 12]. Although procedure duration 
and fluoroscopy time were longer in patients with anomalies, these were not 
statistically significant.  
 
Figure 12. Comparison of patient and procedural data in patients with normal radial 
anatomy and radial anomalies. 
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P=NS 
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Normal radial artery anatomy 
Normal radial artery anatomy (Figure 13) was present in 1321 patients (86.2%). 
Transradial failure rate was low in patients with normal radial anatomy, with 12 
failures out of 1321 patients (0.9%). Procedure failures were due to profound radial 
artery spasm (5 patients, 0.4%), severe brachial artery stenosis (1 patient, <0.1%), 
tortuous subclavian artery (4 patients, 0.3%), radial artery dissection (1 patient, 
<0.1%) and dissection of axillary artery (1 patient, <0.1%).  
 
Radial anomalies 
A summary of anomaly types and associated failure rates is shown in Figure 14. Table 
8 compares patient characteristics and procedural data for different radial anatomical 
patterns. Patients with radial artery loops were significantly older than patients with 
normal anatomy or high bifurcation while extreme radial tortuosity was seen in the 
oldest group. Age was the only independent predictor related to presence of radial 
artery anomaly. 
 
High-bifurcating radial origin 
This was the most frequent radial anomaly (Figure 15) observed in 108 patients with a 
frequency of 7.0%. The majority of these vessels rejoined the brachial artery at the 
level of mid or upper humerus and were of small calibre with over 85% being < 3mm 
in diameter (Figure 16). Importantly, although a high-bifurcating radial artery was not 
associated with a high incidence of transradial failure (5 of 108 patients; 4.6%), many 
of these anomalous vessels were of small calibre and frequently required use of 5F 
catheters with hydrophilic wires to complete the procedure without inducing spasm.   
 
 61 
Figure 13. Normal radial artery anatomy 
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Figure 14.  Types of radial anomaly and their rates of procedural failure. 
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Table  8. Variations of patients and procedural data in relation to radial artery anatomy.  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
*
p value comparing radial anomaly to normal anatomy provided when relevant. 
α
p=NS; 
β
p<0.05; 
Ω
p<0.0001; 
π
p<0.005  
 §
Percentage of failure to radial artery anatomical finding 
 
 
 
 
No. of patients 
(n=1533) 
Normal 
Anatomy 
 
High 
Bifurcations
* 
 
RA Loops
* 
 
Tortuous RA
* 
 
Other 
Anomalies
* 
No. of patients 1321 108 35 30 39 
% of women 28 29
α 
49
β 
50
β 
33
α
 
Age 63.0±11.0 65.5±10.8
α 
69.8±10.4
Ω 
72.2±7.7
Ω 
65.1±11.8
α
 
Procedure 
duration (min)        
 
41.3±21.5 
 
45.2±23.2
α 
 
49.4±17.1
α 
 
41.0±12.7
α 
 
42.1±19.2
α
 
Fluoroscopy 
time (min)   
9.7±8.0 9.3±6.5
α 
10.0±6.6
α 
10.7±6.5
α 
9.6±7.1
α
 
% of failures
§ 0.9 4.6
α 
37.1
Ω 
23.3
π 
12.9%
α
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Figure 15. High bifurcating radial artery that rejoins the brachial artery at the middle 
third of humerus 
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Figure 16. High-bifurcating radial artery – anastomosis sites and diameters. 
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Radial artery loop 
A radial artery loop was observed in 35 patients (2.3%). These mostly involved the 
proximal radial artery just below the brachial bifurcation. A recurrent radial artery 
(occasionally two) was noted to arise from the apex of the loop in all cases, which 
was of small calibre and invariably assumed a straight path into the upper arm. The 
presence of a radial loop was associated with a high procedural failure rate with 13 
out of the 35 procedures (37.1%, p<0.0001) failing to complete. Seven of thirteen 
patients had unfavourable radial loop anatomy with large diameter loops (Figure 17). 
These were considered to be insurmountable by the experienced radial operators and 
the procedure was abandoned from this access site. In the remaining 22 patients, the 
radial loops had a smaller diameter and were ‘crossed’ with a hydrophilic or an 
angioplasty wire. With the loop straightened, the procedure was successfully 
completed (Figure 18a-b). 
 
Extreme radial artery tortuosity 
Extreme radial artery tortuosity (Figure 19) was observed in 30 patients (2.0%). The 
presence of extreme radial tortuosity was also associated with a high procedural 
failure rate with 7 failures (23.3% p<0.001). These vessels were prone to severe radial 
artery spasm; this being the reason for procedure failure in all cases. 
 
Other anomalies  
Various other anomalies were present in 39 patients, giving a combined frequency of 
2.5%.  In 17 patients there was evidence of radial atherosclerosis (1.1%). Of clinical 
interest, in all such patients it was possible to cross with guide wires and catheters. 
However, in 5 patients (29.4%) there was procedural failure due to extreme 
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subclavian tortuosity including retro-oesophageal right subclavian artery (arteria 
lusoria). In the remaining 22 patients a range of minor anatomical variations (such as 
anomalous additional vessels and minor bifurcation variations) were present. These 
had no clinical significance since all cases were completed via the chosen radial 
access site. 
 
Figure 17. Complex large radial artery loops. Note 2 remnant recurrent radial 
arteries assumed a straight path up the arm from the apex of the loop. 
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Figure 18a-b. Example of ‘crossing’ and straightening a radial artery loop. Figure 
18a: ‘Crossing’ the loop with a hydrophilic 0.014” wire. 
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Figure 18b. Straightening of the loop with gentle anti-clockwise rotation of a  
4 French multipurpose diagnostic catheter. 
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Figure 19. Extreme radial artery tortuosity. Note vessel calibre disparity around 
bend probably due to spasm. 
 
 
 
 
Vascular complications 
No patients had bleeding requiring transfusion or surgical intervention. Access site 
vascular complications in 15 patients (1.0%) were treated conservatively. These were: 
small haematoma (8), large haematoma (2), radial artery dissection (2), immediate 
radial artery occlusion (2) and axillary artery dissection (1). Two patients with large 
haematoma were successfully treated with customised compression and arm elevation 
without evidence of compartment syndrome or hand ischaemia. The patient with 
Tortuous radial artery  
Brachial artery 
Ulnar artery 
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axillary artery dissection was also managed conservatively without ischaemic 
sequelae.  
 
3.4 DISCUSSION 
Transradial percutaneous coronary procedures have gained popularity because of 
reduced access site vascular complications and immediate patient mobilisation. 
Procedural success has been facilitated through technological enhancements and 
miniaturisation of equipment. Reported technical failure for transradial procedures is 
between 1-5% (72, 99, 116, 117) compatible with our overall figure of 3.2%. There 
are several reasons leading to failure: inability to puncture, artery spasm and 
anatomical variations. Whereas incidence of the former is documented (72, 99, 116, 
117), information relating to radial artery anatomical variation is limited. 
Furthermore, there is a paucity of data on the presence of radial artery anomaly and its 
relation to procedure failure.  Our data defines radial artery anomalies in patients 
undergoing a first transradial cardiac procedure. Furthermore we observed higher 
procedure failure rates in patients with radial artery anomaly, and of clinical interest, 
different anomalies were associated with different failure rates even for experienced 
operators. Comparisons of selected upper limb arterial anomaly studies are 
summarised on Table 9. 
 
Autopsy studies of upper limb arterial anatomical variation reported a frequency of 
between 4 to 18.5% (113, 115, 118). Using 2-dimensional ultrasonography and colour 
doppler this figure was 9.6% (119) whilst arteriography studies reported between 7.4 
to 22.8% (114, 120, 121).  Not only were there wide variations in the occurrence of 
anomaly, there were also variations in the pattern of anomalies reported, partly due to 
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      Table 9. A summary of selected upper limb arterial anomaly studies 
 
Author Types of Study No. of 
Patients 
or 
Samples  
Mean 
Age 
Incidence of Anomaly                            
 Overall 
(% &  
95% CI) 
High Radial 
Bifurcation 
Radial 
Loop 
Radial 
Tortuosity 
Radial 
Hypoplasia 
Stenosis/ 
Calcification 
Other 
Anomalies 
McCormack 
et al 1953 
Autopsy 750 N/A 18.5 
 
[15.9 - 21.5] 
14.3 0 0 0 0 4.2 
Rodriguez-
Niedenfuhr 
et al 1959 
Autopsy 384 N/A 14.3 
 
[11.2 – 18.2] 
13.8 0 0 0 0 1.0 
Uglietta et 
al 1989 
Arteriography 100 39 9 
 
[4.6 – 16.4] 
8 0 0 0 0 1 
Yokoyama 
et al 2000 
Ultrasonography 115 64.5 9.6 
 
[5.3 – 16.5] 
0 0.9 5.2 1.7 1.7 0 
Yoo et al 
2005 
Arteriography 1191 60 7.4 
 
[6 - 9] 
2.4 0 4.2 0 0 0.9 
Valsecchi et 
al 2006 
Arteriography 2211 62.6 22.8 
 
[21.1 -24.6] 
8.3 0.8 3.8 7.7 1.7 0.5 
Lo et al 
2009 
Arteriography 1026 64 15 
 
[12.1 – 15.6] 
7.8 2.1 2.4 0 1 1.8 
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differences in definitions. The frequency of anatomical variation was higher in 
autopsy studies as variation was defined according to the course of the artery in 
relation to muscle and nerve that would not be evident in arteriographic studies.  
 
An interesting observation from the autopsy studies was an absence of radial artery 
tortuosity or hypoplasia. We postulate that radial artery tortuosity is only seen in the 
presence of a dynamic arterial circulation and therefore not observed at autopsy. The 
absence of hypoplasia in autopsy studies could be explained by arteriographic studies 
reporting existence of “normal” arteries with severe spasm (122). Radial artery 
hypoplasia was not reported in our study nor that by Yoo (120), and Louvard (112). It 
is also worth noting that radial artery loop was not a separate category but under the 
category of variation of anastomosis between brachial artery and radial or ulnar artery 
at elbow level. Furthermore, not all such anastomosis variations were full 360º loops 
as variations could be either in the form of a sling-like loop or rectilinear pattern 
(123). There is therefore no reported frequency of isolated full 360º radial loop from 
autopsy studies.   
 
The most frequent radial artery anomaly observed is high radial bifurcation with a 
reported frequency range of 0% to 14.3%. The absence of high radial bifurcation was 
reported using ultrasonographic scanning suggesting that it is not reliable in 
identifying this type of anomaly (119). However, the small sample size and racial 
variation (115 exclusively Japanese patients) may have been contributory. Yoo et al 
reported a radial bifurcation incidence of 2.4% in 1191 Korean patients (120). The 
reported 7.0% in our study was comparable to the 8.3% reported by Valsecchi et al 
  74 
(121) but lower than the 14% in autopsy studies (113, 115). Importantly, our study 
confirmed that this anomaly did not significantly impact on procedural success. In 
patients with high radial bifurcations with small calibre proximal artery, the use of 5 
French equipment and/or a hydrophilic wire was required for procedure completion. 
  
The presence of a radial artery loop is the commonest cause of procedure failure for 
experienced radial operators (112). The 2.3% frequency of a full 360º radial artery 
loop in our study is the highest reported. All loops were accompanied by a recurrent 
radial artery at the apex of the loop which invariably assumed a straight path into the 
upper arm. The presence of the remnant recurrent radial artery has potential to 
complicate the crossing and straightening manoeuvre, with a tendency for the wire to 
selectively ‘follow’ the path of the remnant artery thereby increasing risk of dissection 
or perforation especially if such anatomy has not been initially defined.  
 
Although loops can often be crossed using either a hydrophilic or an angioplasty wire 
and then straightened with a 5F Judkin Right 4 configuration diagnostic catheter, 
these manoeuvres can induce spasm and pain, making subsequent catheter 
manipulation and advancement impossible. Our procedure failure rate of 37.1% in 
patients with a radial loop was high. However, more than half of these were patients 
with large diameter radial loop anatomy deemed impassable after radial arteriography, 
and procedures were completed via alternative access sites without attempting to 
cross the loops. The early definition of such anatomy at procedure outset informed the 
operator thereby avoiding potential complications.  
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Extreme radial artery tortuosity was also associated with significant procedure failure 
(23.3%). Our strict definition for extreme tortuosity differed from other studies with a 
consequent lower frequency of 2.0%, compared to 3.8%, 4.2% and 5.2% by Valsecchi 
et al, Yoo et al and Yokoyama et al respectively. 
  
Other anomalies observed in our study included a low frequency of radial 
atherosclerosis.  This may be an important marker for extensive extra cardiac vascular 
disease as many such patients were found to have tortuous subclavian vessels that 
could not be navigated, leading to procedural failure. Other minor variations in 
bifurcation anatomy had no influence on procedural outcome. 
 
The acquisition of a radial arteriogram requires only a minimal contrast load, a small 
amount of additional radiation and trivial extra procedural time. This is offset by the 
provision of important information that aids the operator in planning an optimal 
procedure. 
 
In summary, this study demonstrates that radial artery anomalies are relatively 
common and a cause of transradial procedure failure even for experienced radial 
operators. Retrograde radial arteriography helps to delineate underlying anomalies, 
identify patients with unfavourable anatomy thereby informing the operator to plan a 
strategy to overcome the anomaly or change access route with the potential to save 
time and avoid vascular complications. This can be performed with a minimum of 
contrast (3 mls) and should be considered part of a routine transradial procedure.  
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CHAPTER 4 
 
RADIAL ARTERY DIAMETER AND ITS 
RELATIONSHIP TO SUBLINGUAL GTN 
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4.1 INTRODUCTION 
The radial artery is increasingly used as the preferred access route for diagnostic 
catheterisation and therapeutic percutaneous coronary intervention (PCI) since its 
introduction first by Campeau, followed by Kiemeneij and Laarman (38, 40). This is 
driven first by lower access site bleeding complications, improved post-procedural 
patient comfort, day case PCI and economic benefits (43-45, 72, 83, 84, 102, 107, 
124-127), and more recently, by a reduction in mortality when radial access is 
employed for PCI (67). Procedural outcomes have been further evaluated in meta-
analysis of randomised and observational trials confirming that radial access results in 
a reduction of major adverse events and death rate when compared to femoral access 
(46, 95, 128). 
 
The transradial technique is, however, associated with a prolonged learning curve 
frequently related to difficulty in puncturing the radial artery and radial artery spasm, 
even for experienced femoral operators. Detailed knowledge of radial artery diameter 
and any manoeuvre to increase its diameter (for example with Sublingual Glyceryl 
Trinitrate [S/L GTN]) may help shorten part of the learning curve and optimise 
procedural technique, but such data in the western population is currently not 
available. This study aims to evaluate distal upper limb arterial diameters variation 
and their response to S/L GTN in both normal healthy population and in patients with 
pre-specified medical conditions. 
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4.2 METHODS 
Study population 
The study population consists of two groups of subjects: normal healthy individuals 
and patients with coronary artery disease, diabetes mellitus, hypertension, chronic 
renal impairment not on dialysis or peripheral artery disease. Healthy volunteers were 
recruited from staff at University Hospital of North Staffordshire (UHNS) and 
patients with pre-specified medical conditions from Cardiology in-patients. A total of 
305 patients were recruited, of which 125 were healthy subjects. The study was 
approved by the Local Ethics Committee and a written informed consent was obtained 
from each patient. Patients who were unable to give consent or who were acutely 
unwell were excluded. 
 
Ultrasound study of forearm arteries 
Two-dimensional vascular images and colour doppler ultrasonic studies of both the 
right and left forearm arteries were performed by an experienced cardiologist using a 
SonoSite TITAN portable ultrasound system (SonoSite Inc. Bothell, WA, USA) with 
a 10MHz linear vascular transducer (Figure 20). The transducer was placed 
perpendicular to the arterial wall to acquire an optimal image of the vessel. Once in 
position, the site is marked so that the same region of the vessel is imaged during the 
study. The image was recorded in AVU format that and transferred to an external 
computer for analysis later. 
 
The subjects lay supine in a stable temperature room with both arms naturally 
abducted and the wrist supported. The luminal inner diameters of both the right and 
left radial artery (RA) and ulnar artery (UA) were measured 1 to 4cm above the 
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respective styloid process at rest. These were then repeated after administering 800 μg 
of S/L GTN to evaluate the effect of S/L GTN on the right RA and UA diameters. A 
second dose of 800 μg of S/L GTN was administered after at least 30 minutes has 
elapsed to assess the effect of GTN on the left RA and UA diameters. The mean inner 
diameter was defined as an average value of several perpendicular readings. 
 
 
 
 
 
Figure 20. SonoSite Titan ultrasound machine 
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Data Collection 
In addition to bilateral arterial diameters, patient characteristics, wrist circumference, 
hand dominance, Allen’s test and blood pressure (BP) pre and post GTN were all 
recorded. Wrist circumference was measured two centimetres above the radial styloid 
process.  
 
Modified Allen’s test 
The modified Allen’s test is performed by simultaneous compression of both the 
radial and ulnar arteries. The subject is then asked to make a fist and open his hand 
numerous times until the palm of the hand blanches. The compression on the UA is 
then realised. If there is an adequate collateral circulation, the normal colour of the 
palm returns within a few seconds. The Allen’s test is defined as favourable if full 
blushing of the hand occurs with 10 seconds. The test is unfavourable if it takes more 
than 10 seconds for full blushing to occur. For subjects with an unfavourable Allen’s 
test, it will be repeated after measurements of the upper limb arterial diameters post 
S/L GTN. 
 
Reproducibility of measurements of forearm artery diameters 
To assess reproducibility, the forearm diameters in 20 patients were measured twice 
on separate occasions a few weeks apart. 
 
Statistics Analysis 
Statistical analysis was performed using IBM SPSS Statistics 19.0 (IBM Corp., 
Armonk, New York, USA). Categorical data were presented as absolute values and 
percentages whereas continuous data were presented as mean ± standard deviation. 
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The nature of distribution of the data was determined using 1-sample Kolmogorov-
Smirnov test. Student’s t test and Mann-Whitney U test were used to compare 
continuous data as appropriate. Categorical data were compared using the Chi-Square 
test with the appropriate degree of freedom. Both univariate and multivariate 
regression analysis were used to examine potential correlation between radial artery 
diameter and variables such as sex, age, height, body mass index (BMI), hand 
dominance, hypertension, diabetes, chronic renal failure and peripheral vascular 
disease. A p value of less than 0.05 was considered to be statistically significant.  
 
Intra-observer agreement was examined using intraclass correlation coefficient (ICC) 
and their 95% confidence intervals (CI). 
 
4.3 RESULTS 
Patients’ characteristics 
A total of 305 patients were studied. Baseline patient characteristics are summarised 
on Table 10. Figures 21a-h and 22a-h show the histograms and normal distribution 
curve diagrams of the diameters of both the left and right RA and UA in men and 
women. The incidence of unfavourable Allen’s test was low, ranging from 0.6 to 5%. 
Interestingly, all unfavourable Allen’s tests were augmented to become favourable by 
the use of S/L GTN.  
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Table 10. Baseline patient characteristics. 
 
 Male  
(n=150) 
Female  
(n=155) 
P value 
Age 
 
60.1±16.7 57.3±16.9 0.145 
Height (m) 
 
1.77±0.08 1.65±0.06 <0.0005 
Weight (kg) 
 
83.6±13.7 72.4±17.1 <0.0005 
BMI 
 
26.7±4.5 26.7±5.9 0.024 
R wrist circumference (cm) 
 
18.8±1.5 17.0±1.6 <0.0001 
L wrist circumference (cm) 
 
18.4±1.7 16.8±1.6 <0.0001 
Negative R Allen’s test (%) 
 
6 (4%) 7 (4.5%) N/A 
Negative L Allen’s test (%) 
 
4 (2.7%) 8 (5%) N/A 
Bilateral Negative Allen’s test 
(%) 
1 (0.7%) 1 (0.6%) N/A 
Smoker (%) 
 
57 (32%) 46 (30%) 0.64 
Hypertension (%) 
 
38 (25%) 44 (28%) 0.75 
Diabetes (%) 
 
31 (20.7%) 29 (18.7%) 0.82 
Coronary artery disease (%) 
 
45 (30%) 42 (27%) 0.56 
Peripheral vascular disease 
(%) 
8 (5.3%) 10(6.5%) 0.87 
Chronic renal failure (%) 
 
10(6.7%) 10(6.5) 0.92 
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Figure 21a. Histogram of right radial artery diameter pre GTN in men 
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Figure 21b. Histogram of left radial artery diameter pre GTN in men 
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Figure 21c. Histogram of right ulnar artery diameter pre GTN in men 
 
 
 
 
 
 
 
 
 
 
 
  86 
 
 
Figure 21d. Histogram of left ulnar artery diameter pre GTN in men 
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Figure 21e. Histogram of right radial artery diameter post GTN in men 
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Figure 21f. Histogram of left radial artery diameter post GTN in men 
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Figure 21g. Histogram of right ulna artery diameter post GTN in men 
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Figure 21h. Histogram of left ulna artery post GTN in men 
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Figure 22a. Histogram of right radial artery diameter pre GTN in women 
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Figure 22b. Histogram of left radial artery diameter pre GTN in women 
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Figure 22c. Histogram of right ulna artery diameter pre GTN in women 
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Figure 22d. Histogram of left ulna artery diameter pre GTN in women 
 
 
  95 
 
 
Figure 22e. Histogram of right radial artery diameter post GTN in women 
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Figure 22f. Histogram of left radial artery diameter post GTN in women 
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Figure 22g. Histogram of right ulna artery diameter post GTN in women 
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Figure 22h. Histogram of left ulna artery diameter post GTN in women 
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Diameters of forearm arteries and GTN 
The diameters (in mm) of the right (R) and left (L) radial and ulnar arteries pre- and 
post-GTN are listed on Table 11. Men had significantly bigger RA and UA than 
women. The RA was bigger than the UA and the RRA bigger than the LRA in most 
men and women. GTN significantly increase the size of both the RA and UA. Mean 
% dilatation of the RRA, LRA, RUA and LUA in the men was 16.7±8.3, 18.3±6.8, 
19.8±10.6 and 18.7±7.9 respectively, and was 22.9±7.9, 21.0±9.1, 20.8±11.7 and 
20.1±9.6 respectively in women (Figure 23a&b). There were no difference in BP pre 
and post S/L GTN and none of the patients experienced any hypotensive symptoms.  
 
Table 11. Diameters of radial artery, ulnar artery and blood pressure pre and post 
GTN 
 Male  
(n=150) 
Female 
(n=155) 
Mean diameter 
difference 
P value 
Pre GTN 
 
    
RRA (mm) 
 
2.88±0.36 2.23±0.37 0.65 <0.0001 
LRA (mm) 
 
2.63±0.38 2.14±0.35 0.49 <0.0001 
RUA (mm) 
 
2.57±0.36 2.16±0.38 0.41 <0.0001 
LUA (mm) 
 
2.46±0.49 2.09±0.35 0.37 <0.0001 
Post GTN 
 
    
RRA (mm) 
 
3.36±0.40 2.74±0.36 0.62 <0.0001 
LRA (mm) 
 
3.11±0.41 2.59±0.40 0.52 <0.0001 
RUA (mm) 
 
3.08±0.37 2.61±0.35 0.47 <0.0001 
LUA (mm) 
 
2.92±0.47 2.51±, 0.36 0.41 <0.0001 
Blood Pressure 
(mmHg) 
    
Pre GTN  
 
116/72±18/12 113/70±15/10 3/2 NS 
Post GTN  
 
110/68±16/9 106/65±12/9 4/3 NS 
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Figure 23a. Mean diameters (mm) and percentage change of radial and ulnar arteries pre and post S/L GTN in men.  
16.7% 
18.3% 
19.8% 
18.7% 
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Figure 23b. . Mean diameters (mm) and percentage change of radial and ulnar arteries pre and post S/L GTN in women. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22.9% 
21.0% 20.8% 20.1% 
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Radial artery diameters in relation to external diameters of arterial sheaths 
Pre-GTN, only 47.1% and 21.9% of women had RRA bigger than 2.28mm (external 
diameter of a 5F sheath) and 2.52mm (external diameter of a 6F sheath), and 36.1% 
and 11.6% had a LRA bigger than a 5F and 6F sheath respectively (Figure 24b). Post-
GTN, these increased to 91.6% and 78.9% of RRA bigger than a 5F and 6F sheath, 
and 79.4% and 61.9% for LRA respectively. In men, 95.3% and 84.0% had RRA 
bigger than a 5F and 6F sheath respectively, and 85.3% and 70.0% for LRA 
respectively. Post-GTN, these increased to 100% and 97.3% of RRA bigger than a 5F 
and 6F sheath, and 96.7% and 93.3% for LRA respectively (Figure 24a).  
 
Intraclass correlation coefficients 
ICC for intra-observer agreement was excellent ranging from 0.95 for left UA 
measurement (CI 0.91 to 0.97) to 0.97 for right RA measurement (CI 0.94 to 0.98). 
 
Logistic Regression analysis 
Both univariate and multivariate regressions were used to examine the potential 
correlation between radial artery diameter and variables such as sex, age, height, body 
mass index (BMI), hand dominance, coronary artery disease, hypertension, diabetes, 
chronic renal failure and peripheral vascular disease. Sex was the only independent 
predictor of RA size (odds ratio 2.01, CI 1.427-2.353, P<0.005). 
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Figure 24a. Percentage of men with RRA and LRA diameters >2.28mm and >2.52mm, respective external diameters of 5F and 6F arterial 
sheaths. 
 
  Pre GTN Post GTN 
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Figure 24b. Percentage of women with RRA and LRA diameters >2.28mm and >2.52mm, respective external diameters of 5F and 6F arterial 
sheaths. 
 
 
  Pre GTN Post GTN 
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4.4 Discussion 
The RA diameter plays an important role in the success of both arterial puncture and 
transradial cardiac procedures (120, 129, 130), especially during the learning curve. 
The mean RA diameter was shown to be 2.4±0.4mm in Japanese population (129), 
2.6±0.4mm in Korean population (120) and 2.38±0.56mm in the Chinese population 
(131). Yan et al also measured the diameters of both left and right UA in the Chinese 
population, which were found to be of similar size to the RA (131). There are, 
however, limited data on the size of the forearm arterial system in the western 
population. 
 
To the best of our knowledge, our study is the only study that examines all the 
forearm arterial diameters and the effect of S/L GTN in western population using 
doppler ultrasound scan. It shows that the RA is bigger than the UA, in contrast to 
conventional human anatomy teaching (132). One plausible explanation is that the 
proximal UA is bigger than proximal RA before it bifurcates to give off the 
Interrosseou artery, and the distal UA becomes smaller than the RA at around the 
wrist. A study of forearm arterial anatomy in 24 cadevars by Riekkinen shows that the 
mean diameter of the RRA was 28% larger than the RUA, and the LRA 26% larger 
than the LUA (133). Haerle et al, on the other hand, demonstrates that the RA and UA 
are of similar size at the wrist level between the Germans and the Americans (134).  
 
We found that men have bigger RA and UA than women, and the RRA is bigger than 
the LRA in most men and women. More importantly, less than 50% and 22% of 
women have a RRA that is bigger than the external diameter of a 5 French and a 6 
French sheath respectively. This is considerably lower for the LRA. Such proportion 
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in the Asian population would be even lower as the mean diameters of their RRA is 
significantly lower than that of our study. This increases to more than 90% and 80% 
respectively with sublingual GTN. The use of GTN also has the added benefit of 
reducing arterial spasm (in part due to vasodilatation), thus should make arterial 
cannulation and catheter manoeuvre easier. It also has the theoretical benefit of 
reducing the risk of RA occlusion, which is influenced by the ratio of the RA diameter 
and the external diameter of the sheath (135). 
 
An interesting observation with S/L GTN was its effect on blood circulation to the 
hand. All the patients whom were found to have an unfavourable Allen’s test at the 
start of the study had their Allen’s test repeated after administration of S/L GTN. The 
test invariably became favourable, indicating a dynamic circulation that is recruitable.  
 
In summary, the RA is significantly smaller in women than men, with the majority of 
RA in women smaller than the external diameter of a 5F sheath prior to GTN. The RA 
is normally bigger than the UA and the RRA bigger than the LRA in most men and 
women. Sublingual GTN increases the size of the RA significantly and should make 
puncturing the RA easier, thereby shortening part of the learning curve associated 
with the transradial technique. Use of RRA with administration of GTN prior to all 
transradial cardiac procedures is the best policy. 
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CHAPTER 5 
 
RADIATION EXPOSURE AND  
ACCESS SITE SELECTION 
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5.1 INTRODUCTION 
Radiation exposure during cardiac procedures is an essential consideration in relation 
to patient and operator safety as no dose of radiation may be considered safe or 
harmless (136, 137). The transradial access is increasingly utilised to perform 
percutaneous diagnostic and therapeutic coronary procedures in simple and complex 
patient groups as a result of lower access site bleeding complications, improved post-
procedural patient comfort, and economic benefits (47, 83, 84, 111, 138-140). In 
addition, recent observational trials demonstrate a reduction in mortality when radial 
access is employed for percutaneous coronary intervention (PCI) (67, 141). 
Procedural outcomes have been further evaluated in meta-analysis of randomised and 
observational trials confirming that radial access results in a reduction of major 
adverse events and death rate when compared to femoral access (95, 128).  This data 
has lead to the recommendation that radial access is now the gold standard for cardiac 
procedures (142). 
 
An important potential limitation of transradial access is an apparent increase in 
radiation exposure to both patient and operator when compared to transfemoral access 
(102, 139, 143-146). This is a significant issue, since cardiac procedures result in 
considerable radiation exposure for patients and operators (147-155), and a significant 
radial dependent increase would be detrimental. However, the existing published data 
has major methodological flaws (156, 157). The majority of the pre-existing studies 
were poorly controlled and the observed differences in radiation exposure could be 
accounted for by variation in operator experience, angiographic view selection, 
procedure complexity, and the radiation protection protocol used (158, 159). We 
therefore sought to measure radiation exposure to patients and operators according to 
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access site, whilst controlling for other variables that are known to influence radiation 
exposure. 
  
5.2 METHODS 
Study design 
In this study we sought to eliminate the effect of non-access site related influences on 
patient and operator radiation exposure. To minimise the effect of variation in 
procedural complexity, we studied only patients with symptoms of limiting chest pain 
undergoing first time diagnostic angiography (CA) at the University Hospital of North 
Staffordshire (UHNS).  In order to investigate the effect of variations in operator 
expertise, we compared the performance of expert and intermediate operators for both 
access sites.   
 
An operator was defined as an expert if they had performed >2000 cases using their 
chosen access site, and used this default route for >90% of cases. An operator was 
defined as having intermediate experience if they had performed 500-1000 cases 
transfemorally and transradially and used each access site with equal frequency.  
 
The primary aim of this study was to evaluate operator and patient radiation exposure 
during diagnostic CA according to the access site and operator experience. The 
secondary aims were to evaluate access site specific components of procedural 
duration, fluoroscopy time (FT) and time to ambulation.   
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Study population 
One hundred patients undergoing first time diagnostic coronary angiography at UHNS 
were recruited into the study. The experienced transradial (JN) and transfemoral (MG) 
operators each performed 25 consecutive studies using their default approach while 
the intermediate operator (TSL) performed 25 consecutive transradial studies 
followed by 25 consecutive transfemoral studies. 
 
Procedures 
Patients walked into the catheterisation laboratory and were positioned supine on the 
catheterisation table. The puncture area was cleaned with antiseptic and standard 
sterile drapes positioned.  Following instillation of local anaesthetic a vascular sheath 
was positioned in the selected artery via a standard Seldinger technique. For 
transradial cases a transparent adhesive dressing was applied to limit sheath 
movement during catheter exchanges and a vasodilator/anticoagulant cocktail was 
administered. Image aquisition was performed on a digital single-plane 
cineangiography unit with an undertable X-ray tube (Integris, Phillips Medical 
Systems, Eindhoven, Netherlands) using a film speed of 12.5 frames/second. Left 
ventriculography was performed in all cases, using a film speed of 25 frames/second. 
All procedures were performed using 5 French catheters that were 100cm in length. 
For the transfemoral approach standard Judkins and angled pigtail catheters were 
utilised. For the transradial approach a hybrid catheter (Tiger II catheter, Terumo 
Corporation, Tokyo, Japan) was used for coronary angiography with an angled pigtail 
for left ventriculography.   
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A standardised sequence of views of the coronary arteries and left ventricle was 
performed for each procedure. Five standard views were performed for the left 
coronary system: left anterior oblique (LAO) 45º, LAO 45º cranial 30º, right anterior 
oblique (RAO) 45º cranial 30º, RAO 45º, and postero-anterior (PA) caudal 30º. Three 
standard views were performed for the right coronary system using LAO 45º, PA 
cranial 30º and RAO 45º. Left ventriculography was performed in RAO 45º alone.  
 
After acquiring the images, radial sheaths were removed immediately and a 
compression device was applied to obtain haemostasis (TR band, Terumo 
Corporation, Tokyo, Japan). The radial patients then mobilised immediately and 
walked from the table to the recovery area. The transradial patients were then 
encouraged to mobilise immediately within the recovery area. Following image 
acquisition the femoral patients were moved to a trolley which was transferred to the 
recovery area.  The femoral sheath was removed and haemostasis secured by manual 
pressure, followed by four hours bed rest prior to mobilisation. 
 
Radiation protection 
An optimised radiation protection protocol was employed by all operators. This 
included a standard 2-piece lead apron and a thyroid shield worn by each operator. 
Under-table leaded flaps attached to the table and a transparent leaded glass 
suspended from the ceiling (both 0.5mm lead equivalent) were utilised by each 
operator in all procedures. For the transradial procedures, the patient’s right arm was 
fully adducted, after the radial sheath was inserted. Conventional measures such as 
maximising the operator’s distance from the radiation source and minimising the field 
of view were applied in all cases.  
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Measurements and data collection 
Operator effective dose (ED, as µSv) was assessed using an electronic personal 
dosimeter (EPD) incorporating a silicon diode (Figure 25) worn by each operator 
outside the protective lead apron just under the left clavicle. The EPD is highly 
sensitive and has the ability to register radiation doses as low as 0.1 µSv. Patient 
radiation exposure was assessed using the diamentor on the X-ray tube and expressed 
as dose area product (DAP as Gy.cm
2
). Fluoroscopy time (FT) was defined as the 
total screening time of the procedure. Procedural duration was defined as the time 
elapsed (in minutes) from local anaesthetic infiltration to removal of the last catheter 
upon completion of the procedure. Time to ambulation was defined as the time 
elapsed (in minutes) from sheath removal to patient ambulation.  
 
Statistical analysis 
The distribution of continuous data was determined using the 1-sample Kolmogorov-
Smirnov test. Normally distributed data (presented as mean ± 1 standard deviation 
[SD]), and non-parametric data (as median and inter-quartile range [IQR]) were 
compared using the Student’s t test and Mann-Whitney U test respectively. 
Categorical data were presented as absolute values and percentages and compared 
using the Chi-Square test. Both univariate and multivariate regression analyses were 
used to examine potential correlation between continuous variables. A p value of 
<0.05 was considered to be statistically significant. 
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Figure 25. Electronic personal dosimeter 
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5.3 RESULTS 
Patient characteristics 
100 consecutive patients undergoing elective coronary angiography comprised the 
study population. Baseline patient characteristics are detailed in Table 12. The 
patients investigated by the radial expert operator were significantly older than those 
investigated by the femoral operator, but all other patient characteristics were similar.   
 
Radiation exposure and procedural data per access route and operator 
experience 
Primary endpoint: Radiation exposure 
For procedures performed by the intermediate operator, there were no significant 
differences in radiation exposure to either the operator or patients according to access 
site (Table 13b). Similarly, there were no statistically significant differences in 
radiation exposure according to access site for the procedures performed by the expert 
operators (Table 13a). Operator and patient radiation doses were, however, 
significantly increased when comparing the intermediate operator to the expert 
operators for both radial and femoral access sites (table 13e & 13f). 
 
Secondary endpoint: Procedural duration, fluoroscopy time and time to ambulation 
per access route and operator skill level 
Procedural duration was prolonged in both transradial groups as compared to the 
respective transfemoral group (Table 14). The intermediate operator recorded larger 
procedure durations than the expert operators for both access sites. There was, 
however, no difference in FT according to access site at either experience level. The 
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time to ambulation was significantly longer among patients undergoing transfemoral 
procedure (Table 13a-13b).  
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Table 12. Patient characteristics  
 
 
BMI: body mass index 
CAD: coronary artery disease 
 
 
 Radial expert 
operator 
(n=25) 
Femoral expert 
operator 
(n=25) 
P value Radial intermediate 
operator 
(n=25) 
Femoral intermediate 
operator 
(n=25) 
p value 
Male (%) 68 64 NS 72 68 NS 
Age (years) 69.8±7.4 61.4±11.2 0.003 67.4±8.3 66.1±7.7 NS 
Weight (kg) 81.6±13.7 87.5±17.4 NS 75.5±9.2 76.5±7.7 NS 
Height (m) 1.68±0.09 1.68±0.11 NS 1.7±0.07 1.69±0.08 NS 
BMI 28.7±3.2 30.9±5.8 NS 26.1±2.6 26.8±2.4 NS 
Hypertension (%) 56 48 NS 60 52 NS 
Diabetes (%) 24 20 NS 20 20 NS 
CAD 32 28 NS 24 28 NS 
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Table 13: Comparison of radiation and procedural data per skill level.  
ED: effective dose; DAP: dose area product; FT: fluoroscopy time 
 
Table 13a. Radial expert Vs femoral expert 
 Radial expert 
(n=25) 
Femoral expert 
(n=25) 
P value 
 Operator ED  
(µSv) 
6.4±4.7 6.1±5.6 0.85 
Patient DAP (Gy.cm
2
) 21.7±6.5 22.4±8 0.74 
Procedure duration 
(min) 
10.4±2.7 7.3±2.3 <0.001 
FT  
(min) 
1.9±0.9 1.7±1.5 0.69 
Time to ambulation 
(min) 
7.2±2.9 257.2±31.5 <0.0001 
 
 
 
Table 13b. Radial intermediate Vs femoral intermediate 
 Radial 
intermediate 
(n=25) 
Femoral 
intermediate 
(n=25) 
P value 
Operator ED  
(µSv) 
8.8±4.3 8.5±6.5 0.86 
Patient DAP (Gy.cm
2
) 25.4±4.8 25.2±8.3 0.90 
Procedure duration 
(min) 
13.6±2.7 11.3±3.2 0.12 
FT  
(min) 
2.4±0.9 2.2±1.2 0.39 
Time to ambulation 
(min) 
8.0±2.7 255.3±40.1 <0.0001 
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Table 13c. Radial expert Vs femoral Intermediate 
 Radial expert 
(n=25) 
Femoral 
intermediate 
(n=25) 
P value 
Operator ED  
(µSv) 
6.4±4.7 8.5±6.5 0.14 
 Patient DAP (Gy.cm
2
) 21.7±6.5 25.2±8.3 0.68 
Procedure duration 
(min) 
10.4±2.7 11.3±3.2 0.093 
FT  
(min) 
1.9±0.9 2.2±1.2 0.235 
Time to ambulation 
(min) 
7.2±2.9 255.3±40.1 <0.0001 
 
 
 
Table 13d. Radial intermediate Vs Femoral expert 
 Radial 
intermediate 
(n=25) 
Femoral expert 
(n=25) 
P value 
Operator ED  
(µSv) 
8.8±4.3 6.1±5.6 0.002 
 Patient DAP (Gy.cm
2
) 25.4±4.8 22.4±8 0.41 
Procedure duration 
(min) 
13.6±2.7 7.3±2.3 0.001 
FT  
(min) 
2.4±0.9 1.7±1.5 0.001 
Time to ambulation 
(min) 
8.0±2.7 257.2±31.5 <0.0001 
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Table 13e. Radial Expert Vs Radial intermediate 
 Radial expert 
(n=25) 
Radial intermediate 
(n=25) 
P value 
 Operator ED  
(µSv) 
6.4±4.7 8.8±4.3 0.36 
Patient DAP (Gy.cm
2
) 21.7±6.5 25.4±4.8 0.12 
Procedure duration 
(min) 
10.4±2.7 13.6±2.7 0.001 
FT  
(min) 
1.9±0.9 2.4±0.9 0.014 
Time to ambulation 
(min) 
7.2±2.9 8.0±2.7 <0.0001 
 
 
 
 
Table 13f. Femoral expert Vs femoral intermediate 
 Femoral expert 
(n=25) 
Femoral 
intermediate 
(n=25) 
P value 
 Operator ED  
(µSv) 
6.1±5.6 8.5±6.5 0.29 
Patient DAP (Gy.cm
2
) 22.4±8 25.2±8.3 0.138 
Procedure duration 
(min) 
7.3±2.3 11.3±3.2 0.001 
FT  
(min) 
1.7±1.5 2.2±1.2 0.003 
Time to ambulation 
(min) 
257.2±31.5 255.3±40.1 0.91 
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Table 14. Comparison of radiation and procedural data per skill level.  
 
 Radial expert 
(n=25) 
Femoral expert 
(n=25) 
Radial intermediate 
(n=25) 
Femoral intermediate 
(n=25) 
 Operator ED  
(µSv) 
6.4±4.7 6.1±5.6* 8.8±4.3* 8.5±6.5 
Patient DAP 
(Gy.cm
2
) 
21.7±6.5 22.4±8 25.4±4.8 25.2±8.3 
Procedure duration 
(min) 
10.4±2.7
#
 7.3±2.3 13.6±2.7
#
 11.3±3.2
#
 
FT  
(min) 
1.9±0.9
##
 1.7±1.5 2.4±0.9
##
 2.2±1.2
##
 
Time to ambulation 
(min) 
7.2±2.9
###
 257.2±31.5 8.0±2.7
###
 255.3±40.1 
 
ED: effective dose; DAP: dose area product; FT: fluoroscopy time 
 
*  radial intermediate significantly greater than femoral expert only (p=0.002) 
#  all significantly longer than femoral expert (p<0.001) 
## all significantly longer than femoral expert (p<0.01) 
###  radial procedures significantly shorter than femoral procedures (p<0.0001) 
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Table 15. Studies comparing radiation exposure in transfemoral and transradial cardiac catheterisation. 
 
 
DAP = dose area product; FT = fluoroscopy time; RAD Exp = radiation exposure, CA – coronary angiography, PCI – percutaneous coronary intervention. 
 Femoral Artery Radial Artery 
Reference N DAP 
(Gy.cm
2
) 
FT (min) Operator 
Rad Exp 
(µSv) 
N DAP 
(Gy.cm
2
) 
FT (min) Operator 
Rad Exp 
(µSv) 
                   
Mann(143), 1996      
- PCI     
 
126 
   
8.8 
 
138 
   
13.5 
            
Larrazet(160),  2003   
- ad hoc PCI 
 
184 
 
138 
 
12 
  
218 
 
175 
 
17 
 
           
Sandborg(144), 2004          
- CA 
 
40 
 
38±22 
 
4.6±4 
  
36 
 
51±25 
 
7.5±4 
 
- CA + PCI                       42 47±34 12.5±9  24 75±47 18.4±9  
- All 82 43±29 8.6±8  60 61±37 11.9±9  
                   
Geijer(161), 2004     
- PCI 
 
114 
 
69.8 
 
16.4 
  
55 
 
70.5 
 
18.1 
 
                
Lange(145), 2006                     
- CA 
 
103 
 
13.1±8.5 
 
1.7±1.4 
 
32±39 
 
92 
 
15.1±8.4 
 
2.8±2.1 
 
64±55 
- PCI 48 51±29.4 10.4±6.8 110±115 54 46.3±28.7 11.4±8.4 166±188 
 
Brasselet (146), 2008 
- CA 
 
 
- ad hoc PCI 
 
181 
(µSv)            
37.5 
 
 
103 
                     
2.3 
 
 
7.0 
               
13.0 
 
 
41.0 
239 
(µSv )         
59.0 
 
125.5 
                    
4.5 
 
 
10.0 
              
29.0 
 
 
69.5 
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5.4 DISCUSSION 
There are limited published data directly comparing radiation exposure associated 
with transradial and transfemoral approaches [Table 15] (102, 139, 143-146, 160). 
There is a trend to increased fluoroscopy time and higher radiation exposure in 
association with the use of radial access. However, all but one of these are small, non-
randomised observational studies, and with limited control of the patient, operator and 
equipment variables which could affect radiation exposure independent of vascular 
access site.  
 
This study is the first to attempt to isolate and investigate the role of access site 
selection in radiation exposure during cardiac procedures whilst tightly controlling for 
other potential confounding variables.  Our data indicates that when other variables 
are controlled for, transradial access is not associated with an increase in fluoroscopy 
time or radiation exposure to operators or patients. We have shown a small (2 to 3 
minute) increase in on table procedure duration for transradial cases. Following this 
patients mobilise immediately and are self-caring. As reported in previous studies 
patients investigated by transfemoral access require considerably more aftercare and 
mobilisation is delayed for several hours. For both access sites, the intermediate 
operator recorded a 25-30% increase in operator radiation exposure, and a 10-15% 
increase in patient radiation exposure when compared to the expert operator, 
reflecting a learning curve effect for both access sites. 
 
The design of our study was dictated by the need to isolate the potential independent 
effect of access site selection on radiation exposure. We also aimed to investigate the 
effect of variation in operator expertise by comparing results for expert and 
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intermediate level operators. In a study of this nature, a randomised design is usually 
preferable. This would require operators equally skilled in performing procedures 
from both access sites. In our institution the expert operators use their default access 
site almost exclusively, and so have limited expertise in the alternative site. This is a 
common pattern in contemporary practice. Randomising cases for an operator who is 
a high volume operator in one access site, but only an occasional user of the other 
access site, could generate erroneous results due to the effect of differing levels of 
expertise.  We therefore chose to study and compare consecutive cases performed by 
our expert operators to minimise the potential confounding effect of this variable.   
 
We also set out to investigate results for intermediate level operators in both access 
sites.  To do this we needed to compare an operator trained to an intermediate level in 
both transradial and transfemoral procedures. Our interventional fellow (TSL) had 
been trained in the use of both access sites from early in his catheterisation training 
and regularly used both access sites in routine practice, therefore providing an ideal 
subject for this section of the study. By comparing his results with those of the expert 
operators we were able to identify and quantify expertise related effects for both 
access sites. The patient characteristics of our study groups were well balanced, with 
the only significant difference relating to a small increase in mean age in the radial 
expert group. The potential confounding effects of height, weight and BMI are 
therefore minimised, and the small difference in age in one group is unlikely to 
generate major patient related differences in radiation exposure.   
 
The transradial learning curve has previously been studied in detail (42, 110).  
Louvard et al reported procedural failure of 10% in the first 50 cases, improving to 3-
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4% after 500 cases and stabilises at less than 1% after performing more than 1000 
cases (42). Based on Louvard’s data, we selected expert operators whose procedural 
experience would limit the effects of the learning curve and an intermediate operator 
who had completed the most difficult early part of his learning curve. This is in 
contrast to the majority of published studies where the radial operators typically have 
only performed 50-200 transradial cases and are compared with highly experienced 
transfemoral operators (162, 163). In these studies, learning curve effects may have 
had a major influence on results leading to misleading high values for transradial 
related radiation exposure when relatively inexperienced transradial operators were 
compared to expert transfemoral operators.   
 
A unique feature of our study was the strict control of other variables including 
angiographic view selection and procedural complexity, which influence radiation 
exposure to the patient and the operator (136, 144, 164-170). It is therefore, an 
accurate, like-for-like comparison of variation in radiation exposure during diagnostic 
coronary angiography performed via both access sites utilising current best practice. 
Radiation data (for both transradial and transfemoral routes) from our study compare 
favourably to the data published by Brasselet et al (146) and Lange et al (145), both 
of whom reported considerably higher fluoroscopy times, patient and operator 
radiation exposure values. For example, the operator radiation exposure doses 
reported by Brasselet et al (146) were approximately 2- and 4-fold higher than those 
of our trainee and experienced radial operators respectively. Similarly, the doses 
reported by Lange et al (145) were 6- and 10-fold higher. This inter-study variation in 
radiation exposure may be explained by differences in patient-related factors (e.g. 
body mass index, procedural complexity), and procedure-related factors (e.g. operator 
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expertise, operator fatigue, equipment performance, acquisition duration, and training 
and supervision in radiation-reducing techniques), which were uncontrolled for. In 
addition, our study reports results derived from contemporary transradial practice. The 
data on transradial access in previous studies was generated at a point in time when 
transradial equipment and technique was at an earlier stage of development. In 
contemporary practice, many procedural refinements have improved outcomes and 
simplified the procedure (138). Contemporary operators are now well informed about 
issues such as forearm anatomical variations (171) and radial specific catheters (such 
as the Tiger catheter) have been designed to facilitate rapid simple coronary 
cannulation (172). Therefore contemporary transradial operators would be expected to 
have improved performance compared with historical controls.   
 
To date, the study by Lange et al (145) is the only randomised study comparing 
operator and patient radiation exposure utilising experienced radial and femoral 
operators. Although they reported significantly higher radiation exposure to the 
transradial operator, there was no difference in the patients’ radiation exposure for 
either route. As operator radiation exposure is largely a result of back-scatter 
radiation, such discrepancy in radiation exposure could be attributed to a difference in 
application of radiation shielding devices. Close scrutiny of the methods in this study 
reveals that the transfemoral operator had additional radiation shielding (7” protective 
shield flap attached onto the table) that was not used by the transradial operator. 
Consequently, it was not surprising that their transradial operator received a 
significantly higher radiation exposure. This is in keeping with Mann et al who 
demonstrated a significant reduction in radiation exposure for a transradial operator 
over a transfemoral operator could be achieved with the use of additional shielding 
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(143). More recently, the transparent lead glass screen has also been shown to reduce 
operator eye dose by 19-fold (173), although correct positioning of the lead glass 
screen is of crucial importance. Thus the suboptimal radiation protection protocol 
employed by the transradial operator in the Lange study greatly diminishes the 
reliability of the results.   
 
Our study demonstrated that transradial procedure duration is minimally prolonged 
compared to transfemoral cases. This is a reflection of the need for additional 
procedural manoeuvres in transradial cases compared to transfemoral procedures. 
These include administration of intra-arterial vasodilators and heparin following 
sheath insertion, application of adhesive dressings to secure the arterial sheath, and 
reposition of the arm to facilitate optimal radiation protection. The differences in 
procedure duration and FT between the intermediate and expert operators also served 
to show that a learning curve still exist for both the transradial and transfemoral 
approach. It should be emphasised that our procedure duration did not include the 
time elapsed from sheath removal to haemostasis. If such duration were included, the 
total procedure duration for both procedures would have been similar. 
 
We also demonstrated that the time to patient ambulation is markedly reduced for 
transradial procedures. After an elective transradial procedure patients normally 
mobilise and ambulate immediately to encourage overall well-being and normality. 
This results in improved patient comfort, a lower work-load for nursing staff (174), 
and a faster turnover of patients undergoing procedures. These factors will yield 
potential advantages in institutional efficiency and economy. Furthermore, these same 
factors, when allied with the established reductions in access site-related bleeds, 
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support a case for day-case coronary intervention in suitable individuals, which will 
enhance the economic gains. 
 
Limitations 
This was a non-randomised study, but the study design was specifically tailored to the 
requirements of our objective. Femoral closure devices were not used. Although these 
reduce time to ambulation in transfemoral cases, there is a device related increase in 
cost and they do not have a proven effect on complications rates (175). The numbers 
studied were relatively small, and our findings require confirmation in a larger data 
set.  We have not studied operators with limited expertise (less than 500 cases) but our 
data and pre-existing literature suggests that learning curve effects would lead to 
higher values for FT and radiation exposure for these operators and for both access 
sites. Our study was confined to diagnostic coronary angiography only. We have 
previously performed observational studies on single and multi vessel PCI in our 
institution, and demonstrated no increase in FT or radiation exposure in radial cases 
(176) suggesting that the results of the present study can be extrapolated to 
interventional cases.   
 
In summary, transradial diagnostic coronary angiography is not associated with higher 
radiation exposure to the operator or the patient compared to the transfemoral route 
when performed by operators of similar experience employing contemporary 
technique and meticulous radiation protection measures. The time required to patient 
ambulation is markedly reduced following a transradial procedure. Procedures 
performed by operators with lower levels of experience generate higher radiation 
exposure regardless of which access site is employed.  Careful attention to radiation 
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monitoring and protection is required when trainees perform even relatively simple 
procedures such as coronary angiography. 
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CHAPTER 6 
 
APPLICATION OF RADIAL ARTERY ACCESS  
IN TWO HIGH RISK PATIENT SUBGROUPS 
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6.1 INTRODUCTION 
As the radial approach for cardiac catheterisation has been shown to be safe and 
effective with minimal vascular access site complications compared to the femoral 
approach (46, 95), such technique is therefore intuitively suited for patients with high 
bleeding risk. There are currently limited data on the use of transradial approach in 
high risk patient subgroups especially if these patients are unstable. Transfemoral 
approach remains the preferred route in such patients despite being associated and 
responsible for at least two thirds of the bleeding complications that occur in patients 
with acute coronary syndrome managed by invasive strategy (88, 177, 178). This is 
mostly a result of the common belief that the transradial approach requires a specific 
skill set which further increases the procedure complexity of such patients thereby 
adversely affecting their outcome. 
 
This chapter comprises of two studies that aim to evaluate the safety and feasibility of 
utilising the radial access site in the following two high risk patient subgroups: -  
 (1). Patients undergoing rescue angioplasty after failed thrombolytic treatment 
for acute ST segment elevation myocardial infarction, and 
 (2). Patients undergoing left and right heart catheterisation without termination 
of their warfarin therapy. 
 
 
6.2 STUDY 1: TRANSRADIAL RESCUE ANGIOPLASTY 
6.2.1 Introduction 
Intravenous thrombolysis remains the treatment of choice in most countries for 
patients presenting with an acute ST segment elevation myocardial infarction. The 
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incidence of failure to reperfuse is reported to be between 30% and 50% and is 
associated with an adverse prognosis (179). For these patients with reperfusion 
failure, rescue percutaneous coronary intervention (PCI) can be used, but major 
access site bleeding is a risk with the femoral approach. Although percutaneous 
coronary intervention (PCI) via the radial artery route has been established as a safe 
access site in stable patients with low rates of neurovascular complications, little data 
is available on transradial rescue angioplasty. We assessed the procedural and clinical 
outcomes of patients treated with transradial rescue angioplasty for failed 
thrombolysis at two institutions performed by two radial operators between April 
1999 and March 2005. 
 
6.2.2 Methods  
Patient selection  
A transradial program for PCI including rescue angioplasty has been instituted at the 
University Hospital of North Staffordshire since September 1998 (47) and at the 
Brighton and Sussex University Hospital since December 2001. Patients presenting 
with myocardial infarction within 12 hours of the onset of chest pain and evidence of 
failed reperfusion have usually been treated with rescue angioplasty, via the radial 
approach if under the care of JN/DHS (Dr James Nolan and Dr David Hildick-Smith). 
The technique employed has previously been described in detail (180). One hundred 
and five consecutive patients’ data collected prospectively from the two centres were 
analysed retrospectively.  
 
Patients received 5000-10,000 units of intravenous heparin at the start of the 
procedure. Clopidogrel and Aspirin were given in all patients who had a stent 
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procedure. Used of abxicimab (Reopro) was left to operator assessment of risk of 
bleeding and presence of heavy thrombus load. The femoral route was reserved for 
intra-aortic balloon pump (IABP), temporary pacing wire (TPW) or Swan-Ganz (SG) 
catheter insertion. 
 
Patient and procedural data were prospectively collected and during a follow up 
period of 11±8 months. Acute myocardial infarction was diagnosed on the basis of 
typical chest pain lasting more than 30 minutes and associated with new 
electrographic changes (1mm elevation in 2 contiguous limb leads or 2mm elevation 
in 2 contiguous precordial leads). Failure to reperfuse was diagnosed based on 
previously described ECG criteria of failure of the ST segment elevation to fall by 
more than 50% in the lead with maximum elevation at 90 minutes following 
thrombolytic treatment (181). The chest pain to thrombolysis time and the 
thrombolysis to PCI time were recorded in all patients. Procedural duration was 
defined as the time elapsed from entering the catheterization laboratory to leaving the 
laboratory. 
 
6.2.3 Results  
Patients’ characteristics and clinical outcomes are shown in Table 16. The patients 
were relatively young, predominantly male and had sizeable infarct with peak creatine 
kinase of 2823±1734 (706-6890) IU. Ten patients (9.5%) were in cardiogenic shock 
requiring IABP support. The mean time from chest pain to thrombolysis was 155±134 
(10-685) minutes and mean time from thrombolysis to arrival in the catheterization 
laboratory was 221±139 (110-680) minutes. Forty nine patients (47.6%) received 
Streptokinase and 53 patients (52.4%) received Alteplase, Reteplase or Tenecteplase. 
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Radial artery cannulation failed in only 1 patient who had the procedure completed 
via the right brachial artery (femoral access precluded due to peripheral vascular 
disease). At initial coronary angiogram, 91 patients (86.7%) had absent or reduced 
flow in the infarct-related artery. Sixty two patients (59%) had single vessel disease 
and 8 patients (7.6%) had significant left main stem disease (LMS). Procedural 
success (TIMI 3 flow and < 30% residual stenosis) was achieved in 93 patients 
(88.6%). Eight patients (7.6%) had no-reflow phenomenon although one of them had 
a repeat procedure the next day and was successful with the use of Angiojet device.  
 
Stents were deployed in 99 patients (94.3%) with a mean stent of 1.4±0.7. Abciximab 
was used in 37 patients (35.2%). The mean procedural duration was 60±22 (23-133) 
minutes and mean screening time was 11.7±7.2 (3-32) minutes. Overall mortality was 
7.7% (8 patients). Of these, five patients died in hospital, all related to cardiogenic 
shock. Three patients died during post-discharge follow up. Two of the late deaths 
were non-cardiac, the other was a sudden death in a patient who had presented in 
cardiogenic shock. Of the two non cardiac deaths, one died 3 months after discharge 
from aggressive metastatic small cell carcinoma of the lung, the other died from acute 
subarachnoid haemorrhage diagnosed on post mortem. Other MACE rates (10.5%) 
were accounted for by target vessel reinfarction or reintervention and CABG. 
Unusually, there were no follow up target vessel reinfarction or reintervention. 
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Table 16. Patients characteristics and clinical outcomes for rescue PCI 
 
Baseline charecteristics No. % 
Male  90 85.7 
Female 15 14.3 
Age in years: mean±SD and range 60.7±11 37-85 
History of angina/MI 36 34.3 
History of peripheral vascular disease 8 7.6 
Pain to lysis time (mean±SD minutes) 155±134   
Lysis to PTCA time (mean±SD minutes) 221±139   
AMI location     
     Anterior 49 47.0 
     Inferior 56 53.0 
Peak CK (mean±SD) 3105±1536   
Cardiogenic shock 10 9.5 
Stents 99 94.3 
GP2a3b use 37 35.2 
IABP 14 13.3 
Procedural success 93 88.6 
Length of stay (days) (Mean±SD) 7±2   
 
 
Bleeding complications 
There were no radial access vascular complications. Significant gastrointestinal 
bleeding requiring transfusion occurred in three patients (2.9%). There were four 
(3.8%) non-radial vascular access site haematoma. One was a haematoma in the 
patient who required brachial access and the others were femoral haematoma post 
IABP insertion, none of which required transfusion. 
 
6.2.4 Discussion 
Although thrombolytic therapy has long been shown to reduce mortality in patients 
with acute ST segment elevation myocardial infarction (182, 183), 90-minute TIMI 3 
flow is only achieved in 50% of patients with a standard single fibrinolytic agent 
(184, 185). Adjunctive use of Abciximab with Reteplase may increase this to 70%. 
Primary percutaneous coronary intervention (PCI) on the other hand, restores TIMI 3 
flow in 85% to 95% of patients (186, 187) but is not widely available in most 
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countries. The Primary Angioplasty in Myocardial Infarction (PAMI-1) trial showed 
that primary PCI is beneficial for high risk patients (188, 189). Patients with failure to 
reperfuse have also been shown to have a much worse prognosis (190). TIMI 0/1 flow 
combined has a 30-day mortality of 8.8 % compared to 3.7% with TIMI 3 flow (191).  
 
An overview of the available data from early randomised trials and registries suggests 
that rescue PCI reduces the rate of adverse cardiac events after failed thrombolysis 
particularly in patients with a large infarction (75, 192). The most recently published 
randomised trials of rescue PCI (MERLIN and REACT) also show some beneficial 
effects on cardiac events (76, 77). This benefit is partially offset by a high rate of 
vascular complications when femoral access is employed. The reported rate of major 
femoral vascular complications ranges from 4-36%, with most studies reporting rates 
of around 10% (75-77).  
 
Co-administration of Abciximab increases the femoral complication rate further. 
These major femoral complications often required transfusion or vascular intervention 
which increases the patients duration of hospitalization, costs and mortality. This high 
rate of femoral complications is therefore a major drawback of transfemoral rescue 
PCI, and offsets much of the beneficial effect on reduction of adverse cardiac events. 
We have previously reported that transradial access is highly effective in reducing 
vascular complications in stable elective patients (47). We have also studied 
transradial access in anticoagulated patients, reporting a similar low rate of vascular 
complications in patients with an INR > 2 (73). In this study of transradial rescue PCI 
patients we encountered no radial access site complications despite one third of the 
patients receiving additional Glycoprotein IIbIIIa inhibitor therapy. Although 
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important vascular complications such as compartment syndrome complicating a 
large forearm haematoma can occur as a result of radial access, these are very rare and 
did not occur in this small series despite the intensive antithrombotic regime 
employed. These results extend our previous investigations into this high risk 
subgroup, and indicate that transradial access is a safe and effective means of 
preventing vascular access complications in rescue PCI patients.  
 
The data from this study is compatible with the only other published small study of 
transradial rescue PCI. Kassam et al (80) reported similar outcomes in their 45 
transradial rescue PCI patients, with a 95% rate of successful radial cannulation and a 
0% radial access site complication rate despite 100% usage of Glycoprotein IIbIIIa 
inhibitors. They also reported no increase in procedural duration, radiation exposure 
or equipment use for radial procedures when compared to a transfemoral group.  
 
6.3 STUDY 2: PERCUTANEOUS LEFT AND RIGHT HEART 
CATHETERISATION IN FULLY ANTICOAGULATED PATIENTS 
6.3.1 Introduction  
Left and right heart catheterization remains the “gold standard” for accurate 
diagnosis in many cardiac conditions. For most patients it can be safely performed 
via a percutaneous femoral artery and vein approach (femoral approach) as a day 
case procedure with minimal risk. In some patients significant access site 
complications such as large haematoma, pseudoaneurysm or arterio-venous fistula 
formation occur, particularly when procedures are performed in anticoagulated 
patients (193). These risks can be reduced by temporary discontinuation of 
anticoagulants, and the European Society of Cardiology currently recommends that 
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the International Normalised Ratio (INR) should be <1.8 prior to femoral artery 
puncture(194).  
 
For patients receiving oral anticoagulants, reducing the INR significantly increases 
the risks of local or systemic procedure related thromboembolic events (195). 
Thromboembolic risk is particularly high in patients with concomitant poor left 
ventricular function, atrial fibrillation, diabetes, or prosthetic heart valves (194, 195). 
In an effort to reduce this risk many patients are admitted to hospital prior to their 
procedure to allow careful monitoring of the INR while oral anticoagulation is 
withheld, with conversion to heparin (subcutaneous injection or intravenous 
infusion) to cover the period of thromboembolic risk. The experience of heparin used 
during pregnancy in women with prosthetic valves suggests that it is less effective 
than oral anticoagulation in the prevention of thromboembolism (194).  
 
In keeping with this, even with careful monitoring and diligent conversion to 
heparin, thrombo-embolic complications, fulminant valve thrombosis and death have 
been reported with this regime (196). Left and right heart catheterization from the 
femoral approach in patients who require oral anticoagulants is thus not a simple day 
case procedure, and is associated with a considerable risk of bleeding, 
thromboembolism, increased hospital stay and costs. 
 
Left heart catheterization from the radial artery was initially developed as a solution 
to the bleeding complications encountered with the anticoagulation regimes utilized in 
early coronary stent programs (72). This technique reduces the risk of serious 
bleeding complications, minimizes hospital stay and has been widely applied to 
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diagnostic and interventional procedures (47, 72). The first human right heart 
catheterization was reported by Forssman, who used a surgical cut down to canulate 
his own antecubital fossa vein in 1929 (197). Subsequent to this, percutaneous 
puncture of antecubital fossa veins to permit right heart catheterization has been well 
described. This obviates the need for surgical exploration and minimizes the risk of 
central venous cannulation (198-200).  
 
The first reported right and left heart catheterisation from the arm in modern time was 
performed by accident when attempting a transradial left heart catheterisation (201). 
Such an approach has been shown to be technically feasible and has many of the same 
benefits that transradial arterial catheterisation offers (201). Anticoagulated patients 
are thought to be good potential candidates in view of the low incidence of access site 
vascular complications with this technique, but there are currently no data with this 
approach on this high risk patient subgroup. Our study aims to examine the safety and 
feasibility of performing left and right heart catheterization from the arm without 
interruption of oral anticoagulation therapy. 
 
6.3.2 Methods  
Study subjects 
A catheterization programme utilizing transradial access for diagnostic and 
interventional cardiac procedures was instituted at the University Hospital of North 
Staffordshire in September 1998
 
and at the Brighton and Sussex University Hospital 
in December 2001. Patients on oral anticoagulant therapy who required elective right 
and left heart catheterization had the procedures performed via an arm approach 
unless contraindicated. Contraindications for an arm approach, both absolute and 
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relative, include unfavourable Allen’s test, no palpable antecubital fossa veins, flexure 
deformity at the elbow, patients on haemodialysis and INR greater than 5.0. Data on 
consecutive non-anticoagulated patients who underwent a conventional percutaneous 
femoral approach during this time period were collected for comparison. The 
procedures were performed or supervised by consultants experienced in both 
transradial and transfemoral procedures (JN, DHS). All procedures were performed 
without sedation, under local anaesthetic and as day cases. 
 
Vascular puncture and catheterisation technique 
The anticoagulated patients were admitted to the cardiac catheter laboratory and 
prepared as for a standard right radial artery cardiac catheterisation (202, 203). The 
wrist and the antecubital fossa were cleaned with disinfectant (Chlorhexidine). 
Standard femoral drapes were employed with the additional puncture access point 
positioned over the antecubital fossa. A tourniquet was applied to the upper arm 
(away from the disinfected area), an antecubital fossa vein identified by palpation, and 
percutaneous puncture performed. A Seldinger technique was employed to insert a 6F 
sheath into the vein before the tourniquet was removed. The radial artery was then 
punctured and a 5F or 6F sheath inserted (Figure 26). Cannulation of the right heart 
was performed using a 6F Multipurpose A1 (MPA1) end hole catheter over a 0.035J 
shaped guide wire. Measurements of right sided pressures and oxygen saturations 
were obtained. Left heart catheterization, coronary angiography, and pressure 
measurements were performed via the radial artery as previously described (202, 
203). In the non-anticoagulated patients 6F sheaths were positioned in the femoral 
artery and vein using a standard Seldinger technique. Pressure, oxygen saturation and 
angiographic data were obtained using MPA1, Judkins and pigtail catheters. 
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Figure 26. Right radial arterial sheath and right antecubital fossa vein sheath 
after insertion. 
 
 
 
 
Haemostasis technique and postprocedural management 
In the anticoagulated patients both the arterial and venous sheaths were removed at 
the conclusion of the procedure before leaving the catheter laboratory. A RadiStop 
(Radi Medical Systems, Uppsala, Sweden), a customized unilateral compression 
device designed specifically for transradial procedures, was employed for 4 hours to 
achieve arterial haemostasis. A pressure bandage was used for 2-4 hours to achieve 
venous haemostasis. The patients were allowed to mobilise immediately after 
leaving the catheter laboratory and were discharged after four hours observation. In 
the non-anticoagulated patients, the femoral sheaths were removed at the conclusion 
of the procedure in the recovery area. Haemostasis was achieved by direct manual 
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pressure to both puncture sites. A four hour period of bed rest was employed to 
minimize the risk of early re-bleeding. Patients were then mobilized and discharged 
after a further two hours. Procedure duration was defined as the time elapsed from 
patient entry to exit from the catheter laboratory. Fluoroscopy time, total patient 
radiation exposure from the in room diamentor reading and any procedure related 
complications were recorded for each patient.  
 
6.3.3 RESULTS 
A total of 59 patients were recruited, comprising 28 anticoagulated patients and 31 
non-anticoagulated patients. Baseline patient characteristics in the two groups are 
outlined in Table 17. There were no significant differences in baseline characteristics 
between the two groups, apart from an INR of 2.5±0.5 on the day of the procedure in 
the anticoagulated patients. The principal indication for left and right heart 
catheterization related to evaluation of valvular heart disease (48 patients, 81% of the 
study group) with a small proportion (19%) performed for evaluation of atrial septal 
defects (7 patients) or unexplained left ventricular dysfunction (4 patients). The 
commonest reason for chronic oral anticoagulation was the presence of atrial 
fibrillation (25 patients) with the remaining three patients receiving therapy for 
severe heart failure or mural thrombus.  
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Table 17. Baseline patient characteristics for left and right heart catheterisation 
 
 
Characteristics 
Percutaneous 
Arm approach 
(n=28) 
Percutaneous 
Femoral 
approach (n=31) P value 
Age in years  60±12 63±14 NS 
M:F ratio 13 : 15 16 : 15  
Weight (kg) 79.3±16 83.5±18 NS 
Height (cm) 168±15 170±16 NS 
BMI 27.2±7.5 29.4±6.5 NS 
INR 2.5±0.5 1.1±0.1 P<0.005 
Indications for procedure    
      Mitral valve disease 17 (61%) 20 (65%) NS 
      Aortic valve disease 6 (21%) 5 (16%) NS 
      Heart failure 2 (7%) 2 (6%) NS 
      Septal defect 3 (11%) 4 (13%) NS 
 
(mean±SD or number of patients and percentage of group) 
 
Procedural data in the two patient groups is detailed in Table 18. There were no 
contraindications to a percutaneous arm approach in the anticoagulated patients. Left 
heart catheterization was successful achieved using percutaneous puncture of the 
radial artery in all anticoagulated patients. No significant problems with radial spasm 
were encountered. In 27 out of the 28 patients (96%) percutaneous puncture of an 
antecubital fossa vein (medial or lateral antecubital fossa vein) and right heart 
catheterization was successful. In one case direct cut down to identify and cannulate 
a suitable vein was employed as it proved impossible to successfully cannulate an 
antecubital fossa vein. Where difficulty in advancing the venous catheter was 
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encountered, a hydrophilic wire (Terumo Medical Corporation, Somerset, NJ) was 
successfully employed to gain access to the subclavian vein in all subjects, 
regardless of the initial venous puncture position. Full haemodynamic, oxygen 
saturation and angiographic data were obtained and there were no procedure related 
adverse cardiac events. All patients were able to mobilize immediately following the 
procedure, and were discharged as planned at 4 hours after satisfactory haemostasis. 
No thromboembolic or bleeding complications occurred in any of the cohort and no 
late complications were reported at six week follow up.  
 
In all of the non-anticoagulated patients, conventional percutaneous femoral artery 
and vein access was obtained and the procedures were successfully completed with 
no complications. Procedure duration was significantly shorter in this group of 
patients. Fluoroscopy time and radiation exposure values were similar in both 
groups. 
 
 
Table 18. Procedural data (mean±SD or number of patients and percentage of group) 
 
 
Percutaneous  
Arm approach 
(n=28) 
Percutaneous 
Femoral approach 
(n=31) P value 
Access success (%) 27 (96%) 31 (100%)  
Procedural duration (min) 48±15 32±9 P<0.05 
Fluoroscopy time (min) 10.5±6 8±4.5 NS 
Radiation exposure (cGy.m2) 33.9±19 31±17 NS 
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6.3.4 Discussion 
Although this study was performed in a relatively small group of patients, our 
experience of left and right heart catheterisation using percutaneous puncture of the 
radial artery and an antecubital fossa vein suggests that the technique is technically 
feasible, and facilitates safe investigation in fully anticoagulated patients. Since 
hospital admission is not required, costs (compared to those incurred by admission for 
adjustment of anticoagulation to facilitate a femoral procedure) can be constrained. 
More importantly, this technique minimises the thromboembolic risks associated with 
stopping oral anticoagulation. Since haemostasis at the arterial and venous access sites 
is easily achieved by direct pressure, the risk of access site bleeding complications is 
also minimised.  
 
Although vascular punctures in anticoagulated patients have potential risks 
(uncontrolled haemorrhage, haematoma formation and compartment syndrome in 
particular) we did not encounter any haemostatic difficulties in this study. We have 
previously reported no significant access site bleeding in anticoagulated patients (most 
with an INR of 2-3) undergoing coronary angiography via the radial artery without 
interruption of oral anticoagulation (73). We have also studied transradial rescue 
angioplasty in patients who failed to reperfuse following thrombolytic therapy for 
acute ST segment elevation myocardial infarction, and reported no radial access site 
bleeding complications (108). The current study expands this data set, confirming that 
a combined percutaneous approach to the radial artery and antecubital fossa vein is 
safe even in a population of fully anticoagulated patients. Since we utilised separate 
arterial and venous access sites, the risk of arterio-venous fistula formation was also 
minimised. 
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A cut down to the brachial artery may sometimes be the only option in patients with 
severe peripheral vascular disease and bilateral unfavourable Allen’s test undergoing 
cardiac catheterisation procedures. Although it has been shown that skilled operators 
can achieve excellent results with a low rate of access site complications even in 
anticoagulated patients (49), for inexperienced operators this technique is associated 
with unacceptably high access site complications (52). As an alternative, some 
femoral operators employ a percutaneous Seldinger approach to the brachial artery 
(204). The risk of access site complications associated with this technique is also 
unacceptably high for occasional operators (55), with anticoagulated patients being 
particularly susceptible to median nerve compression associated with haematoma 
formation (72, 205). Therefore in anticoagulated patients, the percutaneous approach 
to the brachial artery should be avoided, and a surgical approach reserved for skilled 
high volume operators. 
 
Gilchrist et al reported on 41 left and right heart catheter studies utilising a combined 
percutaneous radial and forearm vein technique (201). The main procedural difference 
in this study was the preferential use of a distal puncture site located close to the wrist.  
In Gilchrist’s series, forearm venous cannulation was not possible in 30% of patients. 
Our failure rate for percutaneous venous cannulation was only 4%.  This improved 
success rate may reflect the use of a less technically demanding proximal venous 
puncture site, suggesting that the antecubital fossa may be preferable for these 
combined procedures. It would be unethical to utilise our technique if it resulted in 
increased complications, radiation exposure or patient discomfort. Our study shows no 
increase in complication rates. There was no significant increase in radiation exposure 
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with our technique, as evidenced by the similar fluoroscopy and radiation exposure 
measurements. Procedure duration was increased compared to a conventional 
percutaneous transfemoral approach. This was predominantly related to the time 
required for identification and puncture of a suitable forearm vein. With increasing 
experience, it is likely that the procedural duration will come down to a level 
comparable to that of a transfemoral approach. It should be noted that the procedural 
duration recorded did not include the longer period of bed rest and observation 
required in the transfemoral patients. Since the patients studied by a percutaneous arm 
approach are mobilized immediately, using this technique will lead to an overall 
reduction in the duration of hospital admission required for the procedure, minimizing 
resource requirements. Early mobilization will also improve patient comfort, 
improving procedure tolerability.   
 
Vascular closure devices can be employed as an alternative to our strategy, with small 
studies demonstrating good results for left heart catheterization in anticoagulated 
patients (206). For left and right studies, the use of vascular closure devices does not 
solve the issue of achieving satisfactory haemostasis after femoral venous puncture in 
anticoagulated patients, when compression can be difficult or painful.  In addition, 
vascular closure devices may fail or be contraindicated in a substantial proportion of 
patients, and may increase the risk of serious vascular complications (207, 208). 
 
Although our data suggests that this technical refinement minimizes the problems 
associated with performing left and right heart catheterization in fully anticoagulated 
patients, the procedural risks associated with every invasive cardiac procedure are not 
abolished. If advances in non-invasive assessment techniques such as 3-dimensional 
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echocardiography, cardiac magnetic resonance and multi-slice computed tomography 
continue at their current pace, the need for assessment by catheterization may be 
greatly reduced, decreasing our reliance on invasive technology. 
 
 
6.4 CONCLUSION 
Whilst both these studies are small observational studies and not withstanding their 
limitations, they nevertheless highlight important points and issues in these 2 high risk 
patient subgroups. 
 
In summary, our rescue PCI study confirms that, for experienced operators, a 
transradial approach substantially reduces the major access site complications 
associated with rescue PCI, allowing reperfusion with minimal vascular risk. Our data 
also suggest that utilizing a transradial approach does not compromise procedural 
outcomes in infarct PCI. Experienced operators could therefore employ radial access 
in a primary PCI program. 
 
Our study on the use of a percutaneous arm technique for right and left heart 
catheterization suggests that in patients treated with oral anticoagulants, the 
combination of left heart catheterization via the radial artery and right heart 
catheterization via an antecubital fossa vein is a useful technique to reduce bleeding 
and thromboembolic risk without interruption to their anticoagulation therapy. In 
addition, this technique also allows early patient mobilisation day case discharge and 
substantial cost saving. 
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CHAPTER 7 
 
CONCLUSIONS 
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7.1 SUMMARY OF RESULTS 
 
Chapter 2 studies the incidence of vascular complications in the modern era in 
relation to femoral and radial access site. A total of 1014 patients are studied. The 
radial access site is associated with a lower incidence of vascular complications than 
the femoral access site. If a vascular complication does occur with the use of radial 
access site, it is often limited and can be treatment conservatively without causing any 
delay to patient discharge. 
 
Chapter 3 studies the incidence of radial artery anatomical variation and its influence 
on procedural outcome in 1540 patients undergoing a transradial cardiac procedure. 
Anomalous radial artery anatomy is common (with an incidence of 15%) although in 
the majority of cases does not affect the outcome of a transradial procedure. The 
commonest type of anomaly is a high bifurcating radial origin which is often 
accompanied by a radial artery of a smaller calibre necessitating the use of 5F 
catheters. The presence of a radial loop is associated with frequent procedure failure. 
 
Retrograde radial arteriography helps to delineate underlying anomalies and identify 
patients with unfavourable anatomy thereby informing the operator to plan a strategy 
to overcome the anomaly or change access route with the potential to save time and 
avoid vascular complications. This can be performed with a minimum of contrast (3 
mls) and should be considered part of a routine transradial procedure 
 
Chapter 4 studies the diameter and response to sublingual GTN of the right and left 
radial and ulnar arteries. The radial artery is bigger than the ulnar artery and the right 
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radial artery than the left radial artery in most men and women. GTN significantly 
increases the size of both the radial and the ulnar arteries. An important finding in this 
study is that majority of women have a radial artery smaller than the external diameter 
of a 5F sheath prior to administration of GTN.  
 
Chapter 5 studies variation in radiation exposure to patients and operators during 
diagnostic transradial and transfemoral coronary angiography, utilising a standardised 
approach and radiation protection protocol. This study demonstrates that transradial 
procedures performed by experienced operators employing meticulous radiation 
protection are not associated with an increase in radiation exposure to the patients or 
the operators.  
 
Chapter 6 studies the application of radial artery access in two high risk patient 
subgroups – patients undergoing transradial rescue PCI following failed 
thrombolytic treatment, and patients undergoing left and right heart catheterisation 
via the radial artery and an ante-cubital fossa vein without stopping their 
anticoagulant therapy.  
 
In the rescue PCI group, the study demonstrates that transradial rescue PCI 
performed by experienced operators is safe and technically feasible, and offers a 
much reduced access site bleeding complications despite use of potent thrombolytic 
and multiple antiplatelet agents.  
 
In the left and right catheterisation group, the study also demonstrates that left and 
right heart catheterisation can be safely performed via the radial artery and an 
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antecubital vein in most fully anticoagulated patients with a low bleeding and 
thromboembolic risk as well as allow early patient mobilization, day case discharge 
and substantial cost saving.   
 
 
7.2 CONCLUSIONS  
Although the radial artery access site is renowned for its much reduced vascular 
complications and has the added benefits of early mobilisation, better patient comfort 
post procedure, cost saving and facilitation of day case PCI, the femoral artery 
remains the preferred access site of choice for most cardiologists. This is to a large 
extent due to the significant learning curve associated with the transradial technique, 
even for experienced femoral operators, as well as concerns regarding higher 
radiation exposure to both the operators and the patients. There is also a general 
misconception that with improvement in technology and equipment used, femoral 
access site vascular complications have become infrequent. 
 
This thesis provides comprehensive information on issues relating to the use of radial 
access site and explores its application in invasive cardiac procedures. Despite 
advances in equipment and improvement in pharmacological agents used, vascular 
access site complications remain a major problem in contemporary practice. We are 
also much more aware of the potential adverse implication associated with significant 
vascular complications, first from observations studies and registries, and more 
recently from meta-analysis and randomised studies. There is therefore a united drive 
to reduce bleeding complications amongst the cardiologists as well as commercial 
partners.  
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Information on radial artery anomalies, variation of radial and ulnar arteries diameters 
as well as the effect of GTN would help to shorten the transradial learning curve and 
optimise procedure technique. Sublingual GTN should make arterial puncturing easier 
as well as reduce the incidence of spasm which is the first hurdle to overcome during 
the learning curve. Retrograde radial arteriography should be undertaken routinely 
especially during the learning curve as it helps to identify patients with unfavourable 
anatomy. The operator could then formalise a strategy to overcome the anomaly or 
change access route to save time and avoid unnecessary vascular complications. 
 
Our study on radiation exposure and access site selection should help refute some of 
the ‘issues’ on radiation exposure. More importantly, this study should also hightlight 
the importance of optimal radiation protection for both the operators as well as the 
patients. There have already been publications of large randomised trials comparing 
transradial and transfemoral approach and their data on radiation exposure is keenly 
awaited. 
 
The radial artery is intuitively suited for high-risk patient subgroups. Since our 
assessment on its application in these groups of patients, we now routinely use the 
radial artery for all comer PCI including primary PCI. 
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7.3 CLINICAL IMPLICATIONS AND FUTURE DIRECTIONS 
It is increasingly obvious that transradial approach should become the default 
approach for all (interventional) cardiologists. Although the transradial technique 
requires a specific skill set and is associated with a significant learning curve, 
information gathered for this thesis would help shorten part of the learning curve as 
well as optimise procedural technique. The majority if not all the trainee cardiologists 
will be proficiently trained in transradial approach in this country. Although there are 
still wide country-to-country variations, the drive to adopt the transradial approach 
has certainly gathered an unstoppable momentum.  
 
Several large observational studies and randomised controlled trials of radial versus 
femoral access had also reported their findings over the last few years. Of note is the 
publication of the radial versus femoral access for coronary intervention in patients 
with acute coronary syndrome (RIVAL) trial (209). This was the largest randomised, 
multicentre trial involving 7021 patients in 32 countries. Although there was no 
difference in the primary outcome (a composite of death, MI, stroke or non-CABG 
related major bleeding) between the two groups, there was a 63% reduction in the risk 
of large vascular access complications with the transradial group. There was, 
however, a 61% relative risk reduction in the risk of death among ST elevation 
myocardial infarction (STEMI) patients treated via the radial route. A sub-group 
analysis also reported a 51% reduction in the risk of the primary outcome among PCI 
centres that performed the highest volume of radial procedures. 
 
A recent meta-analysis of 9 randomised controlled trials that compared the outcomes 
of transradial versus transfemoral route in patients with STEMI PCI also 
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demonstrated a significant reduction in mortality, major adverse cardiac events and 
major access site complications in the transradial group (210). The findings of the 
meta-analysis therefore support the preferential use of radial access for STEMI PCI. 
  
The transradial approach has also now spread to peripheral, renal and carotid 
interventions. The era for (coronary) intervention for the next 10 years will no doubt 
belong to the transradial world. Time will tell! 
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